id	sid	tid	token	lemma	pos
ct-9450	1	1	comparison	comparison	NOUN
ct-9450	1	2	of	of	ADP
ct-9450	1	3	two	two	NUM
ct-9450	1	4	altrenogest	altrenog	ADJ
ct-9450	1	5	preparations	preparation	NOUN
ct-9450	1	6	in	in	ADP
ct-9450	1	7	mares	mare	NOUN
ct-9450	1	8	:	:	PUNCT
ct-9450	1	9	a	a	DET
ct-9450	1	10	pilot	pilot	NOUN
ct-9450	1	11	study	study	NOUN
ct-9450	1	12	comparison	comparison	NOUN
ct-9450	1	13	of	of	ADP
ct-9450	1	14	two	two	NUM
ct-9450	1	15	altrenogest	altrenog	ADJ
ct-9450	1	16	preparations	preparation	NOUN
ct-9450	1	17	in	in	ADP
ct-9450	1	18	mares	mare	NOUN
ct-9450	1	19	:	:	PUNCT
ct-9450	1	20	a	a	DET
ct-9450	1	21	pilot	pilot	NOUN
ct-9450	1	22	study	study	NOUN
ct-9450	1	23	jaymie	jaymie	PROPN
ct-9450	1	24	loy	loy	PROPN
ct-9450	1	25	,	,	PUNCT
ct-9450	1	26	a	a	DET
ct-9450	1	27	scott	scott	PROPN
ct-9450	1	28	norman	norman	PROPN
ct-9450	1	29	,	,	PUNCT
ct-9450	1	30	a	a	PROPN
ct-9450	1	31	-	-	PUNCT
ct-9450	1	32	c	c	NOUN
ct-9450	1	33	heather	heather	NOUN
ct-9450	1	34	ip	ip	PROPN
ct-9450	1	35	,	,	PUNCT
ct-9450	1	36	a	a	PRON
ct-9450	1	37	and	and	CCONJ
ct-9450	1	38	cyril	cyril	PROPN
ct-9450	1	39	stephen	stephen	PROPN
ct-9450	1	40	,	,	PUNCT
ct-9450	1	41	a	a	DET
ct-9450	1	42	,	,	PUNCT
ct-9450	1	43	b	b	X
ct-9450	1	44	aschool	aschool	NOUN
ct-9450	1	45	of	of	ADP
ct-9450	1	46	animal	animal	NOUN
ct-9450	1	47	&	&	CCONJ
ct-9450	1	48	veterinary	veterinary	ADJ
ct-9450	1	49	sciences	sciences	PROPN
ct-9450	1	50	,	,	PUNCT
ct-9450	1	51	charles	charles	PROPN
ct-9450	1	52	sturt	sturt	PROPN
ct-9450	1	53	university	university	PROPN
ct-9450	1	54	,	,	PUNCT
ct-9450	1	55	wagga	wagga	PROPN
ct-9450	1	56	wagga	wagga	PROPN
ct-9450	1	57	,	,	PUNCT
ct-9450	1	58	nsw	nsw	PROPN
ct-9450	1	59	,	,	PUNCT
ct-9450	1	60	australia	australia	PROPN
ct-9450	1	61	bgraham	bgraham	NOUN
ct-9450	1	62	centre	centre	NOUN
ct-9450	1	63	for	for	ADP
ct-9450	1	64	agricultural	agricultural	ADJ
ct-9450	1	65	innovation	innovation	NOUN
ct-9450	1	66	,	,	PUNCT
ct-9450	1	67	charles	charles	PROPN
ct-9450	1	68	sturt	sturt	PROPN
ct-9450	1	69	university	university	PROPN
ct-9450	1	70	,	,	PUNCT
ct-9450	1	71	wagga	wagga	PROPN
ct-9450	1	72	wagga	wagga	PROPN
ct-9450	1	73	,	,	PUNCT
ct-9450	1	74	nsw	nsw	PROPN
ct-9450	1	75	,	,	PUNCT
ct-9450	1	76	australia	australia	PROPN
ct-9450	1	77	ckallangur	ckallangur	PROPN
ct-9450	1	78	veterinary	veterinary	ADJ
ct-9450	1	79	surgery	surgery	NOUN
ct-9450	1	80	,	,	PUNCT
ct-9450	1	81	kallangur	kallangur	PROPN
ct-9450	1	82	,	,	PUNCT
ct-9450	1	83	qld	qld	PROPN
ct-9450	1	84	,	,	PUNCT
ct-9450	1	85	australia	australia	PROPN
ct-9450	1	86	abstract	abstract	ADJ
ct-9450	1	87	altrenogest	altrenogest	NOUN
ct-9450	1	88	is	be	AUX
ct-9450	1	89	a	a	DET
ct-9450	1	90	synthetic	synthetic	ADJ
ct-9450	1	91	progestin	progestin	NOUN
ct-9450	1	92	used	use	VERB
ct-9450	1	93	in	in	ADP
ct-9450	1	94	reproductive	reproductive	ADJ
ct-9450	1	95	management	management	NOUN
ct-9450	1	96	of	of	ADP
ct-9450	1	97	horses	horse	NOUN
ct-9450	1	98	.	.	PUNCT
ct-9450	2	1	aims	aim	NOUN
ct-9450	2	2	were	be	AUX
ct-9450	2	3	to	to	PART
ct-9450	2	4	characterize	characterize	VERB
ct-9450	2	5	and	and	CCONJ
ct-9450	2	6	compare	compare	VERB
ct-9450	2	7	plasma	plasma	NOUN
ct-9450	2	8	altrenogest	altrenogest	NOUN
ct-9450	2	9	concentrations	concentration	NOUN
ct-9450	2	10	associated	associate	VERB
ct-9450	2	11	with	with	ADP
ct-9450	2	12	weekly	weekly	ADJ
ct-9450	2	13	injectable	injectable	NOUN
ct-9450	2	14	versus	versus	ADP
ct-9450	2	15	daily	daily	ADJ
ct-9450	2	16	oral	oral	ADJ
ct-9450	2	17	preparations	preparation	NOUN
ct-9450	2	18	of	of	ADP
ct-9450	2	19	altrenogest	altrenogest	NOUN
ct-9450	2	20	treatments	treatment	NOUN
ct-9450	2	21	.	.	PUNCT
ct-9450	3	1	we	we	PRON
ct-9450	3	2	hypothesized	hypothesize	VERB
ct-9450	3	3	that	that	SCONJ
ct-9450	3	4	an	an	DET
ct-9450	3	5	injectable	injectable	ADJ
ct-9450	3	6	preparation	preparation	NOUN
ct-9450	3	7	would	would	AUX
ct-9450	3	8	not	not	PART
ct-9450	3	9	maintain	maintain	VERB
ct-9450	3	10	concentrations	concentration	NOUN
ct-9450	3	11	higher	high	ADJ
ct-9450	3	12	than	than	ADP
ct-9450	3	13	an	an	DET
ct-9450	3	14	oral	oral	ADJ
ct-9450	3	15	preparation	preparation	NOUN
ct-9450	3	16	given	give	VERB
ct-9450	3	17	once	once	ADV
ct-9450	3	18	weekly	weekly	ADJ
ct-9450	3	19	.	.	PUNCT
ct-9450	4	1	two	two	NUM
ct-9450	4	2	mares	mare	NOUN
ct-9450	4	3	with	with	ADP
ct-9450	4	4	no	no	DET
ct-9450	4	5	in	in	ADP
ct-9450	4	6	vivo	vivo	ADJ
ct-9450	4	7	source	source	NOUN
ct-9450	4	8	of	of	ADP
ct-9450	4	9	progesterone	progesterone	NOUN
ct-9450	4	10	received	receive	VERB
ct-9450	4	11	either	either	DET
ct-9450	4	12	treatment	treatment	NOUN
ct-9450	4	13	a	a	DET
ct-9450	4	14	(	(	PUNCT
ct-9450	4	15	150	150	NUM
ct-9450	4	16	mg	mg	NOUN
ct-9450	4	17	intramuscular	intramuscular	ADJ
ct-9450	4	18	altrenogest	altrenogest	NOUN
ct-9450	4	19	on	on	ADP
ct-9450	4	20	days	day	NOUN
ct-9450	4	21	0	0	NUM
ct-9450	4	22	,	,	PUNCT
ct-9450	4	23	7	7	NUM
ct-9450	4	24	,	,	PUNCT
ct-9450	4	25	and	and	CCONJ
ct-9450	4	26	14	14	NUM
ct-9450	4	27	)	)	PUNCT
ct-9450	4	28	or	or	CCONJ
ct-9450	4	29	treatment	treatment	NOUN
ct-9450	4	30	b	b	PROPN
ct-9450	4	31	(	(	PUNCT
ct-9450	4	32	0.044	0.044	NUM
ct-9450	4	33	mg	mg	PROPN
ct-9450	4	34	/	/	SYM
ct-9450	4	35	kg	kg	PROPN
ct-9450	4	36	bodyweight	bodyweight	NOUN
ct-9450	4	37	of	of	ADP
ct-9450	4	38	oral	oral	ADJ
ct-9450	4	39	altrenogest	altrenogest	ADV
ct-9450	4	40	daily	daily	ADJ
ct-9450	4	41	for	for	ADP
ct-9450	4	42	3	3	NUM
ct-9450	4	43	weeks	week	NOUN
ct-9450	4	44	)	)	PUNCT
ct-9450	4	45	.	.	PUNCT
ct-9450	5	1	after	after	ADP
ct-9450	5	2	a	a	DET
ct-9450	5	3	3	3	NUM
ct-9450	5	4	-	-	PUNCT
ct-9450	5	5	week	week	NOUN
ct-9450	5	6	washout	washout	NOUN
ct-9450	5	7	period	period	NOUN
ct-9450	5	8	,	,	PUNCT
ct-9450	5	9	mares	mare	NOUN
ct-9450	5	10	received	receive	VERB
ct-9450	5	11	the	the	DET
ct-9450	5	12	opposite	opposite	ADJ
ct-9450	5	13	treatment	treatment	NOUN
ct-9450	5	14	for	for	ADP
ct-9450	5	15	3	3	NUM
ct-9450	5	16	weeks	week	NOUN
ct-9450	5	17	.	.	PUNCT
ct-9450	6	1	blood	blood	NOUN
ct-9450	6	2	was	be	AUX
ct-9450	6	3	collected	collect	VERB
ct-9450	6	4	prior	prior	ADV
ct-9450	6	5	to	to	ADP
ct-9450	6	6	treatments	treatment	NOUN
ct-9450	6	7	and	and	CCONJ
ct-9450	6	8	on	on	ADP
ct-9450	6	9	days	day	NOUN
ct-9450	6	10	0	0	NUM
ct-9450	6	11	,	,	PUNCT
ct-9450	6	12	1	1	NUM
ct-9450	6	13	,	,	PUNCT
ct-9450	6	14	4	4	NUM
ct-9450	6	15	,	,	PUNCT
ct-9450	6	16	7	7	NUM
ct-9450	6	17	,	,	PUNCT
ct-9450	6	18	8	8	NUM
ct-9450	6	19	,	,	PUNCT
ct-9450	6	20	11	11	NUM
ct-9450	6	21	,	,	PUNCT
ct-9450	6	22	14	14	NUM
ct-9450	6	23	,	,	PUNCT
ct-9450	6	24	15	15	NUM
ct-9450	6	25	,	,	PUNCT
ct-9450	6	26	18	18	NUM
ct-9450	6	27	,	,	PUNCT
ct-9450	6	28	and	and	CCONJ
ct-9450	6	29	21	21	NUM
ct-9450	6	30	.	.	PUNCT
ct-9450	6	31	high	high	ADJ
ct-9450	6	32	-	-	PUNCT
ct-9450	6	33	performance	performance	NOUN
ct-9450	6	34	liquid	liquid	ADJ
ct-9450	6	35	chromatography	chromatography	NOUN
ct-9450	6	36	-	-	PUNCT
ct-9450	6	37	tandem	tandem	NOUN
ct-9450	6	38	mass	mass	PROPN
ct-9450	6	39	spectrometry	spectrometry	NOUN
ct-9450	6	40	was	be	AUX
ct-9450	6	41	used	use	VERB
ct-9450	6	42	for	for	ADP
ct-9450	6	43	altrenogest	altrenog	ADJ
ct-9450	6	44	assays	assay	NOUN
ct-9450	6	45	.	.	PUNCT
ct-9450	7	1	mean	mean	VERB
ct-9450	7	2	minimum	minimum	ADJ
ct-9450	7	3	plasma	plasma	NOUN
ct-9450	7	4	concentrations	concentration	NOUN
ct-9450	7	5	after	after	ADP
ct-9450	7	6	treatments	treatment	NOUN
ct-9450	7	7	a	a	DET
ct-9450	7	8	and	and	CCONJ
ct-9450	7	9	b	b	NOUN
ct-9450	7	10	were	be	AUX
ct-9450	7	11	1.51	1.51	NUM
ct-9450	7	12	±	±	NUM
ct-9450	7	13	0.65	0.65	NUM
ct-9450	7	14	and	and	CCONJ
ct-9450	7	15	2.38	2.38	NUM
ct-9450	7	16	±	±	NUM
ct-9450	7	17	1.53	1.53	NUM
ct-9450	7	18	ng	ng	PROPN
ct-9450	7	19	/	/	SYM
ct-9450	7	20	ml	ml	PROPN
ct-9450	7	21	,	,	PUNCT
ct-9450	7	22	respectively	respectively	ADV
ct-9450	7	23	.	.	PUNCT
ct-9450	8	1	plasma	plasma	NOUN
ct-9450	8	2	altrenogest	altrenogest	PROPN
ct-9450	8	3	concentrations	concentration	NOUN
ct-9450	8	4	were	be	AUX
ct-9450	8	5	significantly	significantly	ADV
ct-9450	8	6	higher	high	ADJ
ct-9450	8	7	in	in	ADP
ct-9450	8	8	treatment	treatment	NOUN
ct-9450	8	9	a	a	PRON
ct-9450	8	10	than	than	ADP
ct-9450	8	11	treatment	treatment	NOUN
ct-9450	8	12	b	b	NOUN
ct-9450	8	13	at	at	ADP
ct-9450	8	14	24	24	NUM
ct-9450	8	15	hours	hour	NOUN
ct-9450	8	16	posttreatment	posttreatment	NOUN
ct-9450	8	17	(	(	PUNCT
ct-9450	8	18	days	day	NOUN
ct-9450	8	19	1	1	NUM
ct-9450	8	20	,	,	PUNCT
ct-9450	8	21	8	8	NUM
ct-9450	8	22	,	,	PUNCT
ct-9450	8	23	and	and	CCONJ
ct-9450	8	24	15	15	NUM
ct-9450	8	25	)	)	PUNCT
ct-9450	8	26	.	.	PUNCT
ct-9450	9	1	no	no	DET
ct-9450	9	2	significant	significant	ADJ
ct-9450	9	3	difference	difference	NOUN
ct-9450	9	4	between	between	ADP
ct-9450	9	5	plasma	plasma	NOUN
ct-9450	9	6	altrenogest	altrenogest	NOUN
ct-9450	9	7	concentrations	concentration	NOUN
ct-9450	9	8	was	be	AUX
ct-9450	9	9	detected	detect	VERB
ct-9450	9	10	on	on	ADP
ct-9450	9	11	days	day	NOUN
ct-9450	9	12	4	4	NUM
ct-9450	9	13	and	and	CCONJ
ct-9450	9	14	7	7	NUM
ct-9450	9	15	of	of	ADP
ct-9450	9	16	each	each	DET
ct-9450	9	17	week	week	NOUN
ct-9450	9	18	.	.	PUNCT
ct-9450	10	1	finding	find	VERB
ct-9450	10	2	that	that	SCONJ
ct-9450	10	3	plasma	plasma	NOUN
ct-9450	10	4	altrenogest	altrenogest	NOUN
ct-9450	10	5	concentrations	concentration	NOUN
ct-9450	10	6	were	be	AUX
ct-9450	10	7	higher	high	ADJ
ct-9450	10	8	for	for	ADP
ct-9450	10	9	treatment	treatment	NOUN
ct-9450	10	10	a	a	DET
ct-9450	10	11	at	at	ADV
ct-9450	10	12	all	all	DET
ct-9450	10	13	time	time	NOUN
ct-9450	10	14	points	point	NOUN
ct-9450	10	15	except	except	SCONJ
ct-9450	10	16	days	day	NOUN
ct-9450	10	17	7	7	NUM
ct-9450	10	18	,	,	PUNCT
ct-9450	10	19	14	14	NUM
ct-9450	10	20	,	,	PUNCT
ct-9450	10	21	and	and	CCONJ
ct-9450	10	22	21	21	NUM
ct-9450	10	23	supported	support	VERB
ct-9450	10	24	our	our	PRON
ct-9450	10	25	hypothesis	hypothesis	NOUN
ct-9450	10	26	.	.	PUNCT
ct-9450	11	1	an	an	DET
ct-9450	11	2	injectable	injectable	ADJ
ct-9450	11	3	altrenogest	altrenogest	NOUN
ct-9450	11	4	preparation	preparation	NOUN
ct-9450	11	5	may	may	AUX
ct-9450	11	6	be	be	AUX
ct-9450	11	7	considered	consider	VERB
ct-9450	11	8	a	a	DET
ct-9450	11	9	more	more	ADV
ct-9450	11	10	practical	practical	ADJ
ct-9450	11	11	and	and	CCONJ
ct-9450	11	12	safer	safe	ADJ
ct-9450	11	13	solution	solution	NOUN
ct-9450	11	14	for	for	ADP
ct-9450	11	15	long	long	ADJ
ct-9450	11	16	-	-	PUNCT
ct-9450	11	17	term	term	NOUN
ct-9450	11	18	treatment	treatment	NOUN
ct-9450	11	19	;	;	PUNCT
ct-9450	11	20	based	base	VERB
ct-9450	11	21	on	on	ADP
ct-9450	11	22	this	this	DET
ct-9450	11	23	study	study	NOUN
ct-9450	11	24	,	,	PUNCT
ct-9450	11	25	it	it	PRON
ct-9450	11	26	was	be	AUX
ct-9450	11	27	comparable	comparable	ADJ
ct-9450	11	28	to	to	ADP
ct-9450	11	29	a	a	DET
ct-9450	11	30	proven	prove	VERB
ct-9450	11	31	daily	daily	ADJ
ct-9450	11	32	oral	oral	ADJ
ct-9450	11	33	altrenogest	altrenogest	NOUN
ct-9450	11	34	treatment	treatment	NOUN
ct-9450	11	35	for	for	ADP
ct-9450	11	36	a	a	DET
ct-9450	11	37	minimum	minimum	NOUN
ct-9450	11	38	of	of	ADP
ct-9450	11	39	4	4	NUM
ct-9450	11	40	days	day	NOUN
ct-9450	11	41	.	.	PUNCT
ct-9450	12	1	keywords	keyword	NOUN
ct-9450	12	2	:	:	PUNCT
ct-9450	12	3	altrenogest	altrenog	ADJ
ct-9450	12	4	,	,	PUNCT
ct-9450	12	5	equine	equine	NOUN
ct-9450	12	6	,	,	PUNCT
ct-9450	12	7	injectable	injectable	ADJ
ct-9450	12	8	,	,	PUNCT
ct-9450	12	9	oral	oral	ADJ
ct-9450	12	10	,	,	PUNCT
ct-9450	12	11	plasma	plasma	NOUN
ct-9450	12	12	introduction	introduction	NOUN
ct-9450	12	13	altrenogest	altrenogest	NOUN
ct-9450	12	14	is	be	AUX
ct-9450	12	15	a	a	DET
ct-9450	12	16	synthetic	synthetic	ADJ
ct-9450	12	17	progestin	progestin	NOUN
ct-9450	12	18	commonly	commonly	ADV
ct-9450	12	19	used	use	VERB
ct-9450	12	20	in	in	ADP
ct-9450	12	21	mare	mare	NOUN
ct-9450	12	22	reproduction	reproduction	NOUN
ct-9450	12	23	for	for	ADP
ct-9450	12	24	behaviour	behaviour	NOUN
ct-9450	12	25	modification	modification	NOUN
ct-9450	12	26	,	,	PUNCT
ct-9450	12	27	control	control	NOUN
ct-9450	12	28	of	of	ADP
ct-9450	12	29	estrus	estrus	NOUN
ct-9450	12	30	,	,	PUNCT
ct-9450	12	31	maintenance	maintenance	NOUN
ct-9450	12	32	of	of	ADP
ct-9450	12	33	pregnancy	pregnancy	NOUN
ct-9450	12	34	and	and	CCONJ
ct-9450	12	35	uterine	uterine	ADJ
ct-9450	12	36	quiescence	quiescence	NOUN
ct-9450	12	37	,	,	PUNCT
ct-9450	12	38	and	and	CCONJ
ct-9450	12	39	induction	induction	NOUN
ct-9450	12	40	of	of	ADP
ct-9450	12	41	lactation	lactation	NOUN
ct-9450	12	42	in	in	ADP
ct-9450	12	43	nonparturient	nonparturient	NOUN
ct-9450	12	44	mares.1	mares.1	NOUN
ct-9450	12	45	-	-	PUNCT
ct-9450	12	46	4	4	NUM
ct-9450	12	47	such	such	ADJ
ct-9450	12	48	uses	use	NOUN
ct-9450	12	49	require	require	VERB
ct-9450	12	50	altrenogest	altrenog	ADJ
ct-9450	12	51	treatment	treatment	NOUN
ct-9450	12	52	ranging	range	VERB
ct-9450	12	53	from	from	ADP
ct-9450	12	54	10	10	NUM
ct-9450	12	55	120	120	NUM
ct-9450	12	56	days	day	NOUN
ct-9450	12	57	.	.	PUNCT
ct-9450	13	1	currently	currently	ADV
ct-9450	13	2	,	,	PUNCT
ct-9450	13	3	only	only	ADV
ct-9450	13	4	1	1	NUM
ct-9450	13	5	oral	oral	ADJ
ct-9450	13	6	altrenogest	altrenogest	NOUN
ct-9450	13	7	preparation	preparation	NOUN
ct-9450	13	8	is	be	AUX
ct-9450	13	9	available	available	ADJ
ct-9450	13	10	in	in	ADP
ct-9450	13	11	australia	australia	PROPN
ct-9450	13	12	with	with	ADP
ct-9450	13	13	a	a	DET
ct-9450	13	14	demonstrated	demonstrate	VERB
ct-9450	13	15	progestational	progestational	ADJ
ct-9450	13	16	effect	effect	NOUN
ct-9450	13	17	in	in	ADP
ct-9450	13	18	mares	mare	NOUN
ct-9450	13	19	.	.	PUNCT
ct-9450	14	1	however	however	ADV
ct-9450	14	2	,	,	PUNCT
ct-9450	14	3	daily	daily	ADJ
ct-9450	14	4	oral	oral	ADJ
ct-9450	14	5	altrenogest	altrenogest	NOUN
ct-9450	14	6	treatment	treatment	NOUN
ct-9450	14	7	poses	pose	VERB
ct-9450	14	8	risks	risk	NOUN
ct-9450	14	9	to	to	ADP
ct-9450	14	10	personnel	personnel	NOUN
ct-9450	14	11	who	who	PRON
ct-9450	14	12	provide	provide	VERB
ct-9450	14	13	treatment	treatment	NOUN
ct-9450	14	14	,	,	PUNCT
ct-9450	14	15	since	since	SCONJ
ct-9450	14	16	it	it	PRON
ct-9450	14	17	is	be	AUX
ct-9450	14	18	an	an	DET
ct-9450	14	19	oil	oil	NOUN
ct-9450	14	20	-	-	PUNCT
ct-9450	14	21	based	base	VERB
ct-9450	14	22	preparation	preparation	NOUN
ct-9450	14	23	that	that	PRON
ct-9450	14	24	is	be	AUX
ct-9450	14	25	readily	readily	ADV
ct-9450	14	26	absorbed	absorb	VERB
ct-9450	14	27	through	through	ADP
ct-9450	14	28	skin.5	skin.5	PROPN
ct-9450	14	29	human	human	ADJ
ct-9450	14	30	risks	risk	NOUN
ct-9450	14	31	from	from	ADP
ct-9450	14	32	cutaneous	cutaneous	ADJ
ct-9450	14	33	exposure	exposure	NOUN
ct-9450	14	34	include	include	AUX
ct-9450	14	35	disrupted	disrupt	VERB
ct-9450	14	36	menstrual	menstrual	ADJ
ct-9450	14	37	cycles	cycle	NOUN
ct-9450	14	38	,	,	PUNCT
ct-9450	14	39	prolonged	prolonged	ADJ
ct-9450	14	40	pregnancy	pregnancy	NOUN
ct-9450	14	41	,	,	PUNCT
ct-9450	14	42	decreased	decrease	VERB
ct-9450	14	43	libido	libido	NOUN
ct-9450	14	44	in	in	ADP
ct-9450	14	45	men	man	NOUN
ct-9450	14	46	,	,	PUNCT
ct-9450	14	47	headaches	headache	NOUN
ct-9450	14	48	,	,	PUNCT
ct-9450	14	49	fever	fever	NOUN
ct-9450	14	50	,	,	PUNCT
ct-9450	14	51	abdominal	abdominal	ADJ
ct-9450	14	52	pain	pain	NOUN
ct-9450	14	53	,	,	PUNCT
ct-9450	14	54	nausea	nausea	NOUN
ct-9450	14	55	,	,	PUNCT
ct-9450	14	56	diarrhea	diarrhea	NOUN
ct-9450	14	57	,	,	PUNCT
ct-9450	14	58	and	and	CCONJ
ct-9450	14	59	rashes.6	rashes.6	PROPN
ct-9450	14	60	in	in	ADP
ct-9450	14	61	addition	addition	NOUN
ct-9450	14	62	to	to	ADP
ct-9450	14	63	inherent	inherent	ADJ
ct-9450	14	64	safety	safety	NOUN
ct-9450	14	65	risks	risk	NOUN
ct-9450	14	66	to	to	ADP
ct-9450	14	67	personnel	personnel	NOUN
ct-9450	14	68	,	,	PUNCT
ct-9450	14	69	daily	daily	ADJ
ct-9450	14	70	oral	oral	ADJ
ct-9450	14	71	altrenogest	altrenogest	NOUN
ct-9450	14	72	treatment	treatment	NOUN
ct-9450	14	73	is	be	AUX
ct-9450	14	74	logistically	logistically	ADV
ct-9450	14	75	difficult	difficult	ADJ
ct-9450	14	76	and	and	CCONJ
ct-9450	14	77	time	time	NOUN
ct-9450	14	78	consuming.7	consuming.7	PROPN
ct-9450	14	79	,	,	PUNCT
ct-9450	14	80	8	8	NUM
ct-9450	14	81	recent	recent	ADJ
ct-9450	14	82	research	research	NOUN
ct-9450	14	83	has	have	AUX
ct-9450	14	84	focused	focus	VERB
ct-9450	14	85	on	on	ADP
ct-9450	14	86	determining	determine	VERB
ct-9450	14	87	efficacy	efficacy	NOUN
ct-9450	14	88	of	of	ADP
ct-9450	14	89	other	other	ADJ
ct-9450	14	90	routes	route	NOUN
ct-9450	14	91	of	of	ADP
ct-9450	14	92	altrenogest	altrenogest	NOUN
ct-9450	14	93	treatment	treatment	NOUN
ct-9450	14	94	.	.	PUNCT
ct-9450	15	1	although	although	SCONJ
ct-9450	15	2	intrarectal	intrarectal	ADJ
ct-9450	15	3	and	and	CCONJ
ct-9450	15	4	intravaginal	intravaginal	ADJ
ct-9450	15	5	treatments	treatment	NOUN
ct-9450	15	6	of	of	ADP
ct-9450	15	7	altrenogest	altrenog	ADJ
ct-9450	15	8	(	(	PUNCT
ct-9450	15	9	0.044	0.044	NUM
ct-9450	15	10	mg	mg	PROPN
ct-9450	15	11	/	/	SYM
ct-9450	15	12	kg	kg	PROPN
ct-9450	15	13	)	)	PUNCT
ct-9450	15	14	resulted	result	VERB
ct-9450	15	15	in	in	ADP
ct-9450	15	16	absorption	absorption	NOUN
ct-9450	15	17	,	,	PUNCT
ct-9450	15	18	plasma	plasma	NOUN
ct-9450	15	19	concentrations	concentration	NOUN
ct-9450	15	20	were	be	AUX
ct-9450	15	21	significantly	significantly	ADV
ct-9450	15	22	lower	low	ADJ
ct-9450	15	23	than	than	SCONJ
ct-9450	15	24	oral	oral	ADJ
ct-9450	15	25	treatment.5	treatment.5	NOUN
ct-9450	15	26	doubling	double	VERB
ct-9450	15	27	oral	oral	ADJ
ct-9450	15	28	dose	dose	NOUN
ct-9450	15	29	(	(	PUNCT
ct-9450	15	30	0.088	0.088	NUM
ct-9450	15	31	mg	mg	PROPN
ct-9450	15	32	/	/	SYM
ct-9450	15	33	kg	kg	PROPN
ct-9450	15	34	)	)	PUNCT
ct-9450	15	35	was	be	AUX
ct-9450	15	36	recommended	recommend	VERB
ct-9450	15	37	for	for	ADP
ct-9450	15	38	intrarectal	intrarectal	ADJ
ct-9450	15	39	treatment	treatment	NOUN
ct-9450	15	40	to	to	ADP
ct-9450	15	41	mares	mare	NOUN
ct-9450	15	42	unable	unable	ADJ
ct-9450	15	43	or	or	CCONJ
ct-9450	15	44	unwilling	unwilling	ADJ
ct-9450	15	45	to	to	PART
ct-9450	15	46	receive	receive	VERB
ct-9450	15	47	oral	oral	ADJ
ct-9450	15	48	treatment.9	treatment.9	NOUN
ct-9450	15	49	this	this	DET
ct-9450	15	50	treatment	treatment	NOUN
ct-9450	15	51	resulted	result	VERB
ct-9450	15	52	in	in	ADP
ct-9450	15	53	plasma	plasma	NOUN
ct-9450	15	54	concentrations	concentration	NOUN
ct-9450	15	55	>	>	X
ct-9450	15	56	0.5	0.5	NUM
ct-9450	15	57	ng	ng	NOUN
ct-9450	15	58	/	/	SYM
ct-9450	15	59	ml	ml	PROPN
ct-9450	15	60	that	that	PRON
ct-9450	15	61	were	be	AUX
ct-9450	15	62	maintained	maintain	VERB
ct-9450	15	63	for	for	ADP
ct-9450	15	64	5.5	5.5	NUM
ct-9450	15	65	hours	hour	NOUN
ct-9450	15	66	(	(	PUNCT
ct-9450	15	67	range	range	NOUN
ct-9450	15	68	,	,	PUNCT
ct-9450	15	69	3	3	NUM
ct-9450	15	70	8	8	NUM
ct-9450	15	71	hours	hour	NOUN
ct-9450	15	72	)	)	PUNCT
ct-9450	15	73	.	.	PUNCT
ct-9450	16	1	although	although	SCONJ
ct-9450	16	2	intrarectal	intrarectal	ADJ
ct-9450	16	3	treatment	treatment	NOUN
ct-9450	16	4	is	be	AUX
ct-9450	16	5	potentially	potentially	ADV
ct-9450	16	6	useful	useful	ADJ
ct-9450	16	7	for	for	ADP
ct-9450	16	8	mares	mare	NOUN
ct-9450	16	9	that	that	PRON
ct-9450	16	10	can	can	AUX
ct-9450	16	11	not	not	PART
ct-9450	16	12	receive	receive	VERB
ct-9450	16	13	oral	oral	ADJ
ct-9450	16	14	treatment	treatment	NOUN
ct-9450	16	15	,	,	PUNCT
ct-9450	16	16	increased	increase	VERB
ct-9450	16	17	handling	handling	NOUN
ct-9450	16	18	of	of	ADP
ct-9450	16	19	this	this	DET
ct-9450	16	20	hormone	hormone	NOUN
ct-9450	16	21	,	,	PUNCT
ct-9450	16	22	every	every	DET
ct-9450	16	23	4	4	NUM
ct-9450	16	24	8	8	NUM
ct-9450	16	25	hours	hour	NOUN
ct-9450	16	26	,	,	PUNCT
ct-9450	16	27	poses	pose	VERB
ct-9450	16	28	a	a	DET
ct-9450	16	29	greater	great	ADJ
ct-9450	16	30	health	health	NOUN
ct-9450	16	31	risks	risk	NOUN
ct-9450	16	32	to	to	ADP
ct-9450	16	33	personnel	personnel	NOUN
ct-9450	16	34	.	.	PUNCT
ct-9450	17	1	consequently	consequently	ADV
ct-9450	17	2	,	,	PUNCT
ct-9450	17	3	there	there	PRON
ct-9450	17	4	is	be	VERB
ct-9450	17	5	a	a	DET
ct-9450	17	6	need	need	NOUN
ct-9450	17	7	to	to	PART
ct-9450	17	8	ensure	ensure	VERB
ct-9450	17	9	a	a	DET
ct-9450	17	10	more	more	ADV
ct-9450	17	11	convenient	convenient	ADJ
ct-9450	17	12	and	and	CCONJ
ct-9450	17	13	safer	safe	ADJ
ct-9450	17	14	delivery	delivery	NOUN
ct-9450	17	15	method	method	NOUN
ct-9450	17	16	.	.	PUNCT
ct-9450	18	1	in	in	ADP
ct-9450	18	2	recent	recent	ADJ
ct-9450	18	3	years	year	NOUN
ct-9450	18	4	,	,	PUNCT
ct-9450	18	5	despite	despite	SCONJ
ct-9450	18	6	previous	previous	ADJ
ct-9450	18	7	studies	study	NOUN
ct-9450	18	8	supporting	support	VERB
ct-9450	18	9	supplementation	supplementation	NOUN
ct-9450	18	10	of	of	ADP
ct-9450	18	11	>	>	SYM
ct-9450	18	12	225	225	NUM
ct-9450	18	13	mg,10	mg,10	PROPN
ct-9450	18	14	australian	australian	ADJ
ct-9450	18	15	pesticides	pesticide	NOUN
ct-9450	18	16	and	and	CCONJ
ct-9450	18	17	veterinary	veterinary	ADJ
ct-9450	18	18	medicines	medicine	NOUN
ct-9450	18	19	authority	authority	NOUN
ct-9450	18	20	approved	approve	VERB
ct-9450	18	21	treatment	treatment	NOUN
ct-9450	18	22	of	of	ADP
ct-9450	18	23	injectable	injectable	ADJ
ct-9450	18	24	preparations	preparation	NOUN
ct-9450	18	25	of	of	ADP
ct-9450	18	26	altrenogest	altrenog	ADJ
ct-9450	18	27	(	(	PUNCT
ct-9450	18	28	150	150	NUM
ct-9450	18	29	mg/500	mg/500	NOUN
ct-9450	18	30	kg	kg	NOUN
ct-9450	18	31	body	body	NOUN
ct-9450	18	32	weight	weight	NOUN
ct-9450	18	33	every	every	DET
ct-9450	18	34	5	5	NUM
ct-9450	18	35	7	7	NUM
ct-9450	18	36	days	day	NOUN
ct-9450	18	37	)	)	PUNCT
ct-9450	18	38	.	.	PUNCT
ct-9450	19	1	this	this	DET
ct-9450	19	2	reduced	reduce	VERB
ct-9450	19	3	frequency	frequency	NOUN
ct-9450	19	4	of	of	ADP
ct-9450	19	5	handling	handling	NOUN
ct-9450	19	6	may	may	AUX
ct-9450	19	7	be	be	AUX
ct-9450	19	8	a	a	DET
ct-9450	19	9	safer	safe	ADJ
ct-9450	19	10	alternative	alternative	NOUN
ct-9450	19	11	for	for	ADP
ct-9450	19	12	personnel	personnel	NOUN
ct-9450	19	13	.	.	PUNCT
ct-9450	20	1	however	however	ADV
ct-9450	20	2	,	,	PUNCT
ct-9450	20	3	there	there	PRON
ct-9450	20	4	is	be	VERB
ct-9450	20	5	a	a	DET
ct-9450	20	6	need	need	NOUN
ct-9450	20	7	to	to	PART
ct-9450	20	8	assess	assess	VERB
ct-9450	20	9	its	its	PRON
ct-9450	20	10	efficacy	efficacy	NOUN
ct-9450	20	11	or	or	CCONJ
ct-9450	20	12	bioequivalence	bioequivalence	NOUN
ct-9450	20	13	compared	compare	VERB
ct-9450	20	14	to	to	ADP
ct-9450	20	15	a	a	DET
ct-9450	20	16	proven	prove	VERB
ct-9450	20	17	daily	daily	ADJ
ct-9450	20	18	oral	oral	ADJ
ct-9450	20	19	treatment	treatment	NOUN
ct-9450	20	20	regimen	regiman	NOUN
ct-9450	20	21	.	.	PUNCT
ct-9450	21	1	although	although	SCONJ
ct-9450	21	2	pharmacokinetic	pharmacokinetic	ADJ
ct-9450	21	3	studies	study	NOUN
ct-9450	21	4	that	that	PRON
ct-9450	21	5	determined	determine	VERB
ct-9450	21	6	half	half	ADJ
ct-9450	21	7	-	-	PUNCT
ct-9450	21	8	life	life	NOUN
ct-9450	21	9	and	and	CCONJ
ct-9450	21	10	excretion	excretion	NOUN
ct-9450	21	11	rates	rate	NOUN
ct-9450	21	12	of	of	ADP
ct-9450	21	13	injectable	injectable	ADJ
ct-9450	21	14	altrenogest	altrenog	ADJ
ct-9450	21	15	were	be	AUX
ct-9450	21	16	limited	limit	VERB
ct-9450	21	17	to	to	ADP
ct-9450	21	18	a	a	DET
ct-9450	21	19	single	single	ADJ
ct-9450	21	20	dose	dose	NOUN
ct-9450	21	21	treatment	treatment	NOUN
ct-9450	21	22	,	,	PUNCT
ct-9450	21	23	clinical	clinical	ADJ
ct-9450	21	24	cases	case	NOUN
ct-9450	21	25	traditionally	traditionally	ADV
ct-9450	21	26	require	require	VERB
ct-9450	21	27	treatment	treatment	NOUN
ct-9450	21	28	beyond	beyond	ADP
ct-9450	21	29	a	a	DET
ct-9450	21	30	single	single	ADJ
ct-9450	21	31	dose	dose	NOUN
ct-9450	21	32	.	.	PUNCT
ct-9450	22	1	additionally	additionally	ADV
ct-9450	22	2	,	,	PUNCT
ct-9450	22	3	there	there	PRON
ct-9450	22	4	is	be	VERB
ct-9450	22	5	apparently	apparently	ADV
ct-9450	22	6	no	no	DET
ct-9450	22	7	documentation	documentation	NOUN
ct-9450	22	8	of	of	ADP
ct-9450	22	9	plasma	plasma	NOUN
ct-9450	22	10	altrenogest	altrenogest	X
ct-9450	22	11	clinical	clinical	ADJ
ct-9450	22	12	theriogenology	theriogenology	NOUN
ct-9450	22	13	•	•	NOUN
ct-9450	22	14	volume	volume	NOUN
ct-9450	22	15	12	12	NUM
ct-9450	22	16	number	number	NOUN
ct-9450	22	17	4	4	NUM
ct-9450	22	18	•	•	NOUN
ct-9450	22	19	december	december	PROPN
ct-9450	22	20	2020511	2020511	NUM
ct-9450	22	21	concentrations	concentration	NOUN
ct-9450	22	22	(	(	PUNCT
ct-9450	22	23	pac	pac	NOUN
ct-9450	22	24	)	)	PUNCT
ct-9450	22	25	associated	associate	VERB
ct-9450	22	26	with	with	ADP
ct-9450	22	27	oral	oral	ADJ
ct-9450	22	28	altrenogest	altrenogest	NOUN
ct-9450	22	29	treatment	treatment	NOUN
ct-9450	22	30	at	at	ADP
ct-9450	22	31	0.044	0.044	NUM
ct-9450	22	32	mg	mg	PROPN
ct-9450	22	33	/	/	SYM
ct-9450	22	34	kg	kg	PROPN
ct-9450	22	35	for	for	ADP
ct-9450	22	36	the	the	DET
ct-9450	22	37	recommended	recommend	VERB
ct-9450	22	38	treatment	treatment	NOUN
ct-9450	22	39	period	period	NOUN
ct-9450	22	40	of	of	ADP
ct-9450	22	41	15	15	NUM
ct-9450	22	42	days	day	NOUN
ct-9450	22	43	.	.	PUNCT
ct-9450	23	1	objectives	objective	NOUN
ct-9450	23	2	of	of	ADP
ct-9450	23	3	this	this	DET
ct-9450	23	4	pilot	pilot	NOUN
ct-9450	23	5	study	study	NOUN
ct-9450	23	6	were	be	AUX
ct-9450	23	7	to	to	PART
ct-9450	23	8	characterize	characterize	VERB
ct-9450	23	9	plasma	plasma	NOUN
ct-9450	23	10	altrenogest	altrenogest	NOUN
ct-9450	23	11	concentrations	concentration	NOUN
ct-9450	23	12	after	after	ADP
ct-9450	23	13	oral	oral	ADJ
ct-9450	23	14	and	and	CCONJ
ct-9450	23	15	injectable	injectable	ADJ
ct-9450	23	16	preparations	preparation	NOUN
ct-9450	23	17	over	over	ADP
ct-9450	23	18	a	a	DET
ct-9450	23	19	3	3	NUM
ct-9450	23	20	-	-	PUNCT
ct-9450	23	21	week	week	NOUN
ct-9450	23	22	period	period	NOUN
ct-9450	23	23	.	.	PUNCT
ct-9450	24	1	secondly	secondly	ADV
ct-9450	24	2	,	,	PUNCT
ct-9450	24	3	to	to	PART
ct-9450	24	4	determine	determine	VERB
ct-9450	24	5	if	if	SCONJ
ct-9450	24	6	an	an	DET
ct-9450	24	7	injectable	injectable	ADJ
ct-9450	24	8	preparation	preparation	NOUN
ct-9450	24	9	is	be	AUX
ct-9450	24	10	equivalent	equivalent	ADJ
ct-9450	24	11	to	to	ADP
ct-9450	24	12	an	an	DET
ct-9450	24	13	oral	oral	ADJ
ct-9450	24	14	preparation	preparation	NOUN
ct-9450	24	15	for	for	ADP
ct-9450	24	16	the	the	DET
ct-9450	24	17	recommended	recommend	VERB
ct-9450	24	18	7	7	NUM
ct-9450	24	19	-	-	PUNCT
ct-9450	24	20	day	day	NOUN
ct-9450	24	21	treatment	treatment	NOUN
ct-9450	24	22	period	period	NOUN
ct-9450	24	23	,	,	PUNCT
ct-9450	24	24	to	to	PART
ct-9450	24	25	ascertain	ascertain	VERB
ct-9450	24	26	if	if	SCONJ
ct-9450	24	27	injectable	injectable	ADJ
ct-9450	24	28	altrenogest	altrenogest	NOUN
ct-9450	24	29	can	can	AUX
ct-9450	24	30	be	be	AUX
ct-9450	24	31	used	use	VERB
ct-9450	24	32	as	as	ADP
ct-9450	24	33	a	a	DET
ct-9450	24	34	safer	safe	ADJ
ct-9450	24	35	substitute	substitute	NOUN
ct-9450	24	36	for	for	ADP
ct-9450	24	37	oral	oral	ADJ
ct-9450	24	38	altrenogest	altrenogest	NOUN
ct-9450	24	39	.	.	PUNCT
ct-9450	25	1	material	material	NOUN
ct-9450	25	2	and	and	CCONJ
ct-9450	25	3	methods	method	NOUN
ct-9450	25	4	this	this	DET
ct-9450	25	5	research	research	NOUN
ct-9450	25	6	was	be	AUX
ct-9450	25	7	conducted	conduct	VERB
ct-9450	25	8	at	at	ADP
ct-9450	25	9	charles	charles	PROPN
ct-9450	25	10	sturt	sturt	PROPN
ct-9450	25	11	university	university	PROPN
ct-9450	25	12	(	(	PUNCT
ct-9450	25	13	csu	csu	PROPN
ct-9450	25	14	)	)	PUNCT
ct-9450	25	15	,	,	PUNCT
ct-9450	25	16	with	with	ADP
ct-9450	25	17	institutional	institutional	ADJ
ct-9450	25	18	animal	animal	NOUN
ct-9450	25	19	care	care	NOUN
ct-9450	25	20	and	and	CCONJ
ct-9450	25	21	ethics	ethic	NOUN
ct-9450	25	22	committee	committee	PROPN
ct-9450	25	23	approval	approval	NOUN
ct-9450	25	24	(	(	PUNCT
ct-9450	25	25	approval	approval	NOUN
ct-9450	25	26	no	no	INTJ
ct-9450	25	27	.	.	PUNCT
ct-9450	25	28	15/037	15/037	NUM
ct-9450	25	29	)	)	PUNCT
ct-9450	25	30	.	.	PUNCT
ct-9450	26	1	animals	animal	NOUN
ct-9450	26	2	two	two	NUM
ct-9450	26	3	healthy	healthy	ADJ
ct-9450	26	4	mares	mare	NOUN
ct-9450	26	5	aged	age	VERB
ct-9450	26	6	6	6	NUM
ct-9450	26	7	(	(	PUNCT
ct-9450	26	8	horse	horse	NOUN
ct-9450	26	9	1	1	NUM
ct-9450	26	10	;	;	PUNCT
ct-9450	26	11	cleveland	cleveland	PROPN
ct-9450	26	12	bay	bay	PROPN
ct-9450	26	13	;	;	PUNCT
ct-9450	26	14	570	570	NUM
ct-9450	26	15	kg	kg	NOUN
ct-9450	26	16	)	)	PUNCT
ct-9450	26	17	and	and	CCONJ
ct-9450	26	18	8	8	NUM
ct-9450	26	19	(	(	PUNCT
ct-9450	26	20	horse	horse	NOUN
ct-9450	26	21	2	2	NUM
ct-9450	26	22	;	;	PUNCT
ct-9450	26	23	stockhorse	stockhorse	NOUN
ct-9450	26	24	;	;	PUNCT
ct-9450	26	25	458	458	NUM
ct-9450	26	26	kg	kg	NOUN
ct-9450	26	27	)	)	PUNCT
ct-9450	26	28	years	year	NOUN
ct-9450	26	29	,	,	PUNCT
ct-9450	26	30	with	with	ADP
ct-9450	26	31	proven	prove	VERB
ct-9450	26	32	inability	inability	NOUN
ct-9450	26	33	to	to	PART
ct-9450	26	34	produce	produce	VERB
ct-9450	26	35	progesterone	progesterone	NOUN
ct-9450	26	36	from	from	ADP
ct-9450	26	37	a	a	DET
ct-9450	26	38	luteal	luteal	ADJ
ct-9450	26	39	source	source	NOUN
ct-9450	26	40	(	(	PUNCT
ct-9450	26	41	ovariectomized	ovariectomized	ADJ
ct-9450	26	42	and	and	CCONJ
ct-9450	26	43	hypoplastic	hypoplastic	ADJ
ct-9450	26	44	ovaries	ovary	NOUN
ct-9450	26	45	,	,	PUNCT
ct-9450	26	46	respectively	respectively	ADV
ct-9450	26	47	)	)	PUNCT
ct-9450	26	48	,	,	PUNCT
ct-9450	26	49	were	be	AUX
ct-9450	26	50	used	use	VERB
ct-9450	26	51	in	in	ADP
ct-9450	26	52	this	this	DET
ct-9450	26	53	pilot	pilot	NOUN
ct-9450	26	54	study	study	NOUN
ct-9450	26	55	.	.	PUNCT
ct-9450	27	1	treatment	treatment	NOUN
ct-9450	27	2	and	and	CCONJ
ct-9450	27	3	blood	blood	NOUN
ct-9450	27	4	sampling	sample	VERB
ct-9450	27	5	this	this	DET
ct-9450	27	6	study	study	NOUN
ct-9450	27	7	was	be	AUX
ct-9450	27	8	conducted	conduct	VERB
ct-9450	27	9	between	between	ADP
ct-9450	27	10	june	june	PROPN
ct-9450	27	11	and	and	CCONJ
ct-9450	27	12	august	august	PROPN
ct-9450	27	13	2015	2015	NUM
ct-9450	27	14	as	as	ADP
ct-9450	27	15	a	a	DET
ct-9450	27	16	bioequivalence	bioequivalence	NOUN
ct-9450	27	17	crossover	crossover	ADP
ct-9450	27	18	design	design	NOUN
ct-9450	27	19	trial	trial	NOUN
ct-9450	27	20	.	.	PUNCT
ct-9450	28	1	both	both	DET
ct-9450	28	2	mares	mare	NOUN
ct-9450	28	3	received	receive	VERB
ct-9450	28	4	either	either	DET
ct-9450	28	5	treatment	treatment	NOUN
ct-9450	28	6	a	a	DET
ct-9450	28	7	(	(	PUNCT
ct-9450	28	8	3	3	NUM
ct-9450	28	9	ml	ml	NOUN
ct-9450	28	10	of	of	ADP
ct-9450	28	11	50	50	NUM
ct-9450	28	12	mg	mg	NOUN
ct-9450	28	13	/	/	SYM
ct-9450	28	14	ml	ml	X
ct-9450	28	15	intramuscular	intramuscular	ADJ
ct-9450	28	16	altrenogest	altrenogest	ADV
ct-9450	29	1	[	[	X
ct-9450	29	2	ovu	ovu	ADJ
ct-9450	29	3	-	-	PUNCT
ct-9450	29	4	mate	mate	NOUN
ct-9450	29	5	®	®	NOUN
ct-9450	29	6	;	;	PUNCT
ct-9450	29	7	randlab	randlab	NOUN
ct-9450	29	8	,	,	PUNCT
ct-9450	29	9	chipping	chip	VERB
ct-9450	29	10	norton	norton	NOUN
ct-9450	29	11	,	,	PUNCT
ct-9450	29	12	nsw	nsw	PROPN
ct-9450	29	13	,	,	PUNCT
ct-9450	29	14	australia	australia	PROPN
ct-9450	29	15	]	]	PUNCT
ct-9450	29	16	)	)	PUNCT
ct-9450	29	17	on	on	ADP
ct-9450	29	18	days	day	NOUN
ct-9450	29	19	0	0	NUM
ct-9450	29	20	,	,	PUNCT
ct-9450	29	21	7	7	NUM
ct-9450	29	22	,	,	PUNCT
ct-9450	29	23	and	and	CCONJ
ct-9450	29	24	14	14	NUM
ct-9450	29	25	)	)	PUNCT
ct-9450	29	26	or	or	CCONJ
ct-9450	29	27	treatment	treatment	NOUN
ct-9450	29	28	b	b	PROPN
ct-9450	29	29	(	(	PUNCT
ct-9450	29	30	0.044	0.044	NUM
ct-9450	29	31	mg	mg	PROPN
ct-9450	29	32	/	/	SYM
ct-9450	29	33	kg	kg	PROPN
ct-9450	29	34	bodyweight	bodyweight	PROPN
ct-9450	29	35	daily	daily	ADV
ct-9450	29	36	oral	oral	ADJ
ct-9450	29	37	altrenogest	altrenogest	NOUN
ct-9450	30	1	[	[	X
ct-9450	30	2	regumate	regumate	NOUN
ct-9450	30	3	®	®	NOUN
ct-9450	30	4	;	;	PUNCT
ct-9450	30	5	intervet	intervet	NOUN
ct-9450	30	6	,	,	PUNCT
ct-9450	30	7	bendigo	bendigo	PROPN
ct-9450	30	8	,	,	PUNCT
ct-9450	30	9	vic	vic	PROPN
ct-9450	30	10	,	,	PUNCT
ct-9450	30	11	australia	australia	PROPN
ct-9450	30	12	]	]	PUNCT
ct-9450	30	13	)	)	PUNCT
ct-9450	30	14	for	for	ADP
ct-9450	30	15	3	3	NUM
ct-9450	30	16	weeks	week	NOUN
ct-9450	30	17	.	.	PUNCT
ct-9450	31	1	after	after	ADP
ct-9450	31	2	a	a	DET
ct-9450	31	3	3	3	NUM
ct-9450	31	4	-	-	PUNCT
ct-9450	31	5	week	week	NOUN
ct-9450	31	6	wash	wash	NOUN
ct-9450	31	7	-	-	PUNCT
ct-9450	31	8	out	out	ADP
ct-9450	31	9	period	period	NOUN
ct-9450	31	10	,	,	PUNCT
ct-9450	31	11	mares	mare	NOUN
ct-9450	31	12	received	receive	VERB
ct-9450	31	13	the	the	DET
ct-9450	31	14	opposite	opposite	ADJ
ct-9450	31	15	treatment	treatment	NOUN
ct-9450	31	16	for	for	ADP
ct-9450	31	17	a	a	DET
ct-9450	31	18	further	further	ADJ
ct-9450	31	19	3	3	NUM
ct-9450	31	20	weeks	week	NOUN
ct-9450	31	21	.	.	PUNCT
ct-9450	32	1	venous	venous	ADJ
ct-9450	32	2	blood	blood	NOUN
ct-9450	32	3	was	be	AUX
ct-9450	32	4	collected	collect	VERB
ct-9450	32	5	into	into	ADP
ct-9450	32	6	heparinised	heparinise	VERB
ct-9450	32	7	tubes	tube	NOUN
ct-9450	32	8	(	(	PUNCT
ct-9450	32	9	10	10	NUM
ct-9450	32	10	ml	ml	NOUN
ct-9450	32	11	)	)	PUNCT
ct-9450	32	12	for	for	ADP
ct-9450	32	13	plasma	plasma	NOUN
ct-9450	32	14	altrenogest	altrenogest	NOUN
ct-9450	32	15	assay	assay	VERB
ct-9450	32	16	,	,	PUNCT
ct-9450	32	17	prior	prior	ADV
ct-9450	32	18	to	to	ADP
ct-9450	32	19	treatments	treatment	NOUN
ct-9450	32	20	(	(	PUNCT
ct-9450	32	21	day	day	NOUN
ct-9450	32	22	0	0	NUM
ct-9450	32	23	)	)	PUNCT
ct-9450	32	24	and	and	CCONJ
ct-9450	32	25	on	on	ADP
ct-9450	32	26	days	day	NOUN
ct-9450	32	27	1	1	NUM
ct-9450	32	28	,	,	PUNCT
ct-9450	32	29	4	4	NUM
ct-9450	32	30	,	,	PUNCT
ct-9450	32	31	7	7	NUM
ct-9450	32	32	,	,	PUNCT
ct-9450	32	33	8	8	NUM
ct-9450	32	34	,	,	PUNCT
ct-9450	32	35	11	11	NUM
ct-9450	32	36	,	,	PUNCT
ct-9450	32	37	14	14	NUM
ct-9450	32	38	,	,	PUNCT
ct-9450	32	39	15	15	NUM
ct-9450	32	40	,	,	PUNCT
ct-9450	32	41	18	18	NUM
ct-9450	32	42	,	,	PUNCT
ct-9450	32	43	and	and	CCONJ
ct-9450	32	44	21	21	NUM
ct-9450	32	45	.	.	PUNCT
ct-9450	33	1	assay	assay	PROPN
ct-9450	33	2	and	and	CCONJ
ct-9450	33	3	data	datum	NOUN
ct-9450	33	4	analysis	analysis	NOUN
ct-9450	33	5	samples	sample	NOUN
ct-9450	33	6	were	be	AUX
ct-9450	33	7	analyzed	analyze	VERB
ct-9450	33	8	for	for	ADP
ct-9450	33	9	pac	pac	PROPN
ct-9450	33	10	using	use	VERB
ct-9450	33	11	high	high	ADJ
ct-9450	33	12	-	-	PUNCT
ct-9450	33	13	performance	performance	NOUN
ct-9450	33	14	liquid	liquid	ADJ
ct-9450	33	15	chromatography	chromatography	NOUN
ct-9450	33	16	-	-	PUNCT
ct-9450	33	17	tandem	tandem	NOUN
ct-9450	33	18	mass	mass	ADJ
ct-9450	33	19	spectrometry	spectrometry	NOUN
ct-9450	33	20	(	(	PUNCT
ct-9450	33	21	lcms	lcms	PROPN
ct-9450	33	22	-	-	PUNCT
ct-9450	33	23	ms	ms	PROPN
ct-9450	33	24	)	)	PUNCT
ct-9450	33	25	in	in	ADP
ct-9450	33	26	a	a	DET
ct-9450	33	27	commercial	commercial	ADJ
ct-9450	33	28	laboratory	laboratory	NOUN
ct-9450	33	29	(	(	PUNCT
ct-9450	33	30	pia	pia	PROPN
ct-9450	33	31	pharma	pharma	PROPN
ct-9450	33	32	pty	pty	PROPN
ct-9450	33	33	ltd	ltd	PROPN
ct-9450	33	34	)	)	PUNCT
ct-9450	33	35	,	,	PUNCT
ct-9450	33	36	according	accord	VERB
ct-9450	33	37	to	to	ADP
ct-9450	33	38	methods	method	NOUN
ct-9450	33	39	previously	previously	ADV
ct-9450	33	40	reported.11	reported.11	VERB
ct-9450	33	41	quantitative	quantitative	ADJ
ct-9450	33	42	analysis	analysis	NOUN
ct-9450	33	43	was	be	AUX
ct-9450	33	44	based	base	VERB
ct-9450	33	45	on	on	ADP
ct-9450	33	46	an	an	DET
ct-9450	33	47	internal	internal	ADJ
ct-9450	33	48	standardization	standardization	NOUN
ct-9450	33	49	using	use	VERB
ct-9450	33	50	c21h24o2	c21h24o2	PROPN
ct-9450	33	51	,	,	PUNCT
ct-9450	33	52	gestrinone	gestrinone	NOUN
ct-9450	33	53	with	with	ADP
ct-9450	33	54	a	a	DET
ct-9450	33	55	molecular	molecular	ADJ
ct-9450	33	56	weight	weight	NOUN
ct-9450	33	57	of	of	ADP
ct-9450	33	58	308.421	308.421	NUM
ct-9450	33	59	g	g	NOUN
ct-9450	33	60	/	/	SYM
ct-9450	33	61	mol	mol	NOUN
ct-9450	33	62	.	.	PUNCT
ct-9450	34	1	in	in	ADP
ct-9450	34	2	comparison	comparison	NOUN
ct-9450	34	3	,	,	PUNCT
ct-9450	34	4	altrenogest	altrenogest	NOUN
ct-9450	34	5	structure	structure	NOUN
ct-9450	34	6	is	be	AUX
ct-9450	34	7	c21h26o2	c21h26o2	NOUN
ct-9450	34	8	with	with	ADP
ct-9450	34	9	a	a	DET
ct-9450	34	10	molecular	molecular	ADJ
ct-9450	34	11	weight	weight	NOUN
ct-9450	34	12	of	of	ADP
ct-9450	34	13	310.437	310.437	NUM
ct-9450	34	14	g	g	NOUN
ct-9450	34	15	/	/	SYM
ct-9450	34	16	mol	mol	NOUN
ct-9450	34	17	.	.	PUNCT
ct-9450	35	1	a	a	DET
ct-9450	35	2	calibration	calibration	NOUN
ct-9450	35	3	curve	curve	NOUN
ct-9450	35	4	,	,	PUNCT
ct-9450	35	5	prepared	prepare	VERB
ct-9450	35	6	with	with	ADP
ct-9450	35	7	concentrations	concentration	NOUN
ct-9450	35	8	ranging	range	VERB
ct-9450	35	9	from	from	ADP
ct-9450	35	10	1	1	NUM
ct-9450	35	11	to	to	ADP
ct-9450	35	12	50	50	NUM
ct-9450	35	13	ng	ng	NOUN
ct-9450	35	14	/	/	SYM
ct-9450	35	15	ml	ml	NOUN
ct-9450	35	16	altrenogest	altrenogest	NOUN
ct-9450	35	17	,	,	PUNCT
ct-9450	35	18	was	be	AUX
ct-9450	35	19	used	use	VERB
ct-9450	35	20	for	for	ADP
ct-9450	35	21	quantitation	quantitation	NOUN
ct-9450	35	22	.	.	PUNCT
ct-9450	36	1	correlation	correlation	NOUN
ct-9450	36	2	coefficient	coefficient	NOUN
ct-9450	36	3	(	(	PUNCT
ct-9450	36	4	r	r	NOUN
ct-9450	36	5	)	)	PUNCT
ct-9450	36	6	was	be	AUX
ct-9450	36	7	0.9996	0.9996	NUM
ct-9450	36	8	which	which	PRON
ct-9450	36	9	met	meet	VERB
ct-9450	36	10	in	in	ADP
ct-9450	36	11	-	-	PUNCT
ct-9450	36	12	house	house	NOUN
ct-9450	36	13	criteria	criterion	NOUN
ct-9450	36	14	(	(	PUNCT
ct-9450	36	15	r	r	NOUN
ct-9450	36	16	>	>	X
ct-9450	36	17	0.99	0.99	NUM
ct-9450	36	18	)	)	PUNCT
ct-9450	36	19	.	.	PUNCT
ct-9450	37	1	the	the	DET
ct-9450	37	2	analyst	analyst	NOUN
ct-9450	37	3	was	be	AUX
ct-9450	37	4	blinded	blind	VERB
ct-9450	37	5	to	to	PART
ct-9450	37	6	treatments	treatment	NOUN
ct-9450	37	7	.	.	PUNCT
ct-9450	38	1	differences	difference	NOUN
ct-9450	38	2	in	in	ADP
ct-9450	38	3	pac	pac	PROPN
ct-9450	38	4	between	between	ADP
ct-9450	38	5	treatment	treatment	NOUN
ct-9450	38	6	routes	route	NOUN
ct-9450	38	7	were	be	AUX
ct-9450	38	8	analyzed	analyze	VERB
ct-9450	38	9	for	for	ADP
ct-9450	38	10	days	day	NOUN
ct-9450	38	11	1	1	NUM
ct-9450	38	12	,	,	PUNCT
ct-9450	38	13	4	4	NUM
ct-9450	38	14	,	,	PUNCT
ct-9450	38	15	and	and	CCONJ
ct-9450	38	16	7	7	NUM
ct-9450	38	17	of	of	ADP
ct-9450	38	18	each	each	DET
ct-9450	38	19	week	week	NOUN
ct-9450	38	20	(	(	PUNCT
ct-9450	38	21	days	day	NOUN
ct-9450	38	22	1	1	NUM
ct-9450	38	23	,	,	PUNCT
ct-9450	38	24	4	4	NUM
ct-9450	38	25	,	,	PUNCT
ct-9450	38	26	7	7	NUM
ct-9450	38	27	,	,	PUNCT
ct-9450	38	28	8	8	NUM
ct-9450	38	29	,	,	PUNCT
ct-9450	38	30	11	11	NUM
ct-9450	38	31	,	,	PUNCT
ct-9450	38	32	14	14	NUM
ct-9450	38	33	,	,	PUNCT
ct-9450	38	34	15	15	NUM
ct-9450	38	35	,	,	PUNCT
ct-9450	38	36	18	18	NUM
ct-9450	38	37	and	and	CCONJ
ct-9450	38	38	21	21	NUM
ct-9450	38	39	)	)	PUNCT
ct-9450	38	40	using	use	VERB
ct-9450	38	41	a	a	DET
ct-9450	38	42	series	series	NOUN
ct-9450	38	43	of	of	ADP
ct-9450	38	44	paired	pair	VERB
ct-9450	38	45	student	student	NOUN
ct-9450	38	46	’s	’s	PART
ct-9450	38	47	t	t	PROPN
ct-9450	38	48	-	-	PUNCT
ct-9450	38	49	tests	test	NOUN
ct-9450	38	50	.	.	PUNCT
ct-9450	39	1	interactions	interaction	NOUN
ct-9450	39	2	between	between	ADP
ct-9450	39	3	pac	pac	PROPN
ct-9450	39	4	and	and	CCONJ
ct-9450	39	5	time	time	NOUN
ct-9450	39	6	were	be	AUX
ct-9450	39	7	tested	test	VERB
ct-9450	39	8	by	by	ADP
ct-9450	39	9	repeated	repeat	VERB
ct-9450	39	10	measures	measure	NOUN
ct-9450	39	11	analysis	analysis	NOUN
ct-9450	39	12	using	use	VERB
ct-9450	39	13	mixed	mixed	ADJ
ct-9450	39	14	procedure	procedure	NOUN
ct-9450	39	15	of	of	ADP
ct-9450	39	16	sas	sas	PROPN
ct-9450	39	17	.	.	PUNCT
ct-9450	40	1	results	result	VERB
ct-9450	40	2	daily	daily	ADJ
ct-9450	40	3	oral	oral	ADJ
ct-9450	40	4	altrenogest	altrenogest	NOUN
ct-9450	40	5	treatment	treatment	NOUN
ct-9450	40	6	resulted	result	VERB
ct-9450	40	7	in	in	ADP
ct-9450	40	8	minimum	minimum	NOUN
ct-9450	40	9	pac	pac	PROPN
ct-9450	40	10	between	between	ADP
ct-9450	40	11	0.87	0.87	NUM
ct-9450	40	12	and	and	CCONJ
ct-9450	40	13	4.17	4.17	NUM
ct-9450	40	14	ng	ng	PROPN
ct-9450	40	15	/	/	SYM
ct-9450	40	16	ml	ml	PROPN
ct-9450	40	17	(	(	PUNCT
ct-9450	40	18	table	table	NOUN
ct-9450	40	19	)	)	PUNCT
ct-9450	40	20	.	.	PUNCT
ct-9450	41	1	weekly	weekly	ADJ
ct-9450	41	2	altrenogest	altrenog	ADJ
ct-9450	41	3	injections	injection	NOUN
ct-9450	41	4	resulted	result	VERB
ct-9450	41	5	in	in	ADP
ct-9450	41	6	minimum	minimum	NOUN
ct-9450	41	7	pac	pac	PROPN
ct-9450	41	8	ranging	range	VERB
ct-9450	41	9	from	from	ADP
ct-9450	41	10	0.64	0.64	NUM
ct-9450	41	11	to	to	ADP
ct-9450	41	12	2.79	2.79	NUM
ct-9450	41	13	ng	ng	NOUN
ct-9450	41	14	/	/	SYM
ct-9450	41	15	ml	ml	NOUN
ct-9450	41	16	over	over	ADP
ct-9450	41	17	the	the	DET
ct-9450	41	18	treatment	treatment	NOUN
ct-9450	41	19	period	period	NOUN
ct-9450	41	20	(	(	PUNCT
ct-9450	41	21	table	table	NOUN
ct-9450	41	22	)	)	PUNCT
ct-9450	41	23	.	.	PUNCT
ct-9450	42	1	table	table	NOUN
ct-9450	42	2	.	.	PUNCT
ct-9450	43	1	plasma	plasma	NOUN
ct-9450	43	2	altrenogest	altrenogest	PROPN
ct-9450	43	3	concentrations	concentration	NOUN
ct-9450	43	4	(	(	PUNCT
ct-9450	43	5	ng	ng	NOUN
ct-9450	43	6	/	/	SYM
ct-9450	43	7	ml	ml	NOUN
ct-9450	43	8	)	)	PUNCT
ct-9450	43	9	over	over	ADP
ct-9450	43	10	21	21	NUM
ct-9450	43	11	-	-	PUNCT
ct-9450	43	12	day	day	NOUN
ct-9450	43	13	treatment	treatment	NOUN
ct-9450	43	14	period	period	NOUN
ct-9450	43	15	treatment	treatment	NOUN
ct-9450	43	16	group	group	NOUN
ct-9450	43	17	day	day	PROPN
ct-9450	43	18	day	day	NOUN
ct-9450	43	19	day	day	NOUN
ct-9450	43	20	day	day	NOUN
ct-9450	43	21	day	day	NOUN
ct-9450	43	22	day	day	NOUN
ct-9450	43	23	day	day	NOUN
ct-9450	43	24	day	day	NOUN
ct-9450	43	25	day	day	NOUN
ct-9450	43	26	day	day	NOUN
ct-9450	43	27	0	0	NUM
ct-9450	43	28	1	1	NUM
ct-9450	43	29	4	4	NUM
ct-9450	43	30	7	7	NUM
ct-9450	43	31	8	8	NUM
ct-9450	43	32	11	11	NUM
ct-9450	43	33	14	14	NUM
ct-9450	43	34	15	15	NUM
ct-9450	43	35	18	18	NUM
ct-9450	43	36	21	21	NUM
ct-9450	43	37	horse	horse	NOUN
ct-9450	43	38	1	1	NUM
ct-9450	43	39	a	a	DET
ct-9450	43	40	<	<	X
ct-9450	43	41	0.5	0.5	NUM
ct-9450	43	42	13.16	13.16	NUM
ct-9450	43	43	2.38	2.38	NUM
ct-9450	43	44	0.64	0.64	NUM
ct-9450	43	45	14.37	14.37	NUM
ct-9450	43	46	4.31	4.31	NUM
ct-9450	43	47	1.6	1.6	NUM
ct-9450	43	48	17.2	17.2	NUM
ct-9450	43	49	4.05	4.05	NUM
ct-9450	43	50	1.31	1.31	NUM
ct-9450	43	51	b	b	NOUN
ct-9450	43	52	<	<	X
ct-9450	43	53	0.5	0.5	NUM
ct-9450	43	54	1.79	1.79	NUM
ct-9450	43	55	3.36	3.36	NUM
ct-9450	43	56	3.8	3.8	NUM
ct-9450	43	57	3.57	3.57	NUM
ct-9450	43	58	3.36	3.36	NUM
ct-9450	43	59	3.89	3.89	NUM
ct-9450	43	60	3.25	3.25	NUM
ct-9450	43	61	4.17	4.17	NUM
ct-9450	43	62	3.63	3.63	NUM
ct-9450	43	63	horse	horse	NOUN
ct-9450	43	64	2	2	NUM
ct-9450	43	65	a	a	DET
ct-9450	43	66	<	<	X
ct-9450	43	67	0.5	0.5	NUM
ct-9450	43	68	13.29	13.29	NUM
ct-9450	43	69	3.86	3.86	NUM
ct-9450	43	70	1.2	1.2	NUM
ct-9450	43	71	10.91	10.91	NUM
ct-9450	43	72	3.21	3.21	NUM
ct-9450	43	73	1.51	1.51	NUM
ct-9450	43	74	7.52	7.52	NUM
ct-9450	43	75	3.09	3.09	NUM
ct-9450	43	76	2.79	2.79	NUM
ct-9450	43	77	b	b	NOUN
ct-9450	43	78	<	<	X
ct-9450	43	79	0.5	0.5	NUM
ct-9450	43	80	0.96	0.96	NUM
ct-9450	43	81	1.06	1.06	NUM
ct-9450	43	82	0.87	0.87	NUM
ct-9450	43	83	1.03	1.03	NUM
ct-9450	43	84	0.93	0.93	NUM
ct-9450	43	85	1.13	1.13	NUM
ct-9450	43	86	1.02	1.02	NUM
ct-9450	43	87	0.87	0.87	NUM
ct-9450	43	88	0.96	0.96	NUM
ct-9450	43	89	a.	a.	NOUN
ct-9450	43	90	injectable	injectable	NOUN
ct-9450	43	91	altrenogest	altrenogest	ADV
ct-9450	43	92	once	once	ADV
ct-9450	43	93	weekly	weekly	ADV
ct-9450	43	94	(	(	PUNCT
ct-9450	43	95	days	day	NOUN
ct-9450	43	96	0	0	NUM
ct-9450	43	97	,	,	PUNCT
ct-9450	43	98	7	7	NUM
ct-9450	43	99	,	,	PUNCT
ct-9450	43	100	and	and	CCONJ
ct-9450	43	101	14	14	NUM
ct-9450	43	102	)	)	PUNCT
ct-9450	43	103	intramuscular	intramuscular	ADV
ct-9450	43	104	;	;	PUNCT
ct-9450	43	105	b.	b.	PROPN
ct-9450	43	106	oral	oral	PROPN
ct-9450	43	107	altrenogest	altrenogest	ADV
ct-9450	43	108	once	once	ADV
ct-9450	43	109	daily	daily	ADV
ct-9450	43	110	for	for	ADP
ct-9450	43	111	21	21	NUM
ct-9450	43	112	days	day	NOUN
ct-9450	43	113	clinical	clinical	ADJ
ct-9450	43	114	theriogenology	theriogenology	NOUN
ct-9450	43	115	•	•	NOUN
ct-9450	43	116	volume	volume	NOUN
ct-9450	43	117	12	12	NUM
ct-9450	43	118	number	number	NOUN
ct-9450	43	119	4	4	NUM
ct-9450	43	120	•	•	NOUN
ct-9450	43	121	december	december	PROPN
ct-9450	43	122	2020	2020	NUM
ct-9450	43	123	512	512	NUM
ct-9450	43	124	mean	mean	NOUN
ct-9450	43	125	minimum	minimum	PROPN
ct-9450	43	126	pac	pac	PROPN
ct-9450	43	127	following	follow	VERB
ct-9450	43	128	treatment	treatment	NOUN
ct-9450	43	129	a	a	PRON
ct-9450	43	130	and	and	CCONJ
ct-9450	43	131	treatment	treatment	NOUN
ct-9450	43	132	b	b	PROPN
ct-9450	43	133	were	be	AUX
ct-9450	43	134	1.51	1.51	NUM
ct-9450	43	135	±	±	NUM
ct-9450	43	136	0.65	0.65	NUM
ct-9450	43	137	and	and	CCONJ
ct-9450	43	138	2.38	2.38	NUM
ct-9450	43	139	±	±	NUM
ct-9450	43	140	1.53	1.53	NUM
ct-9450	43	141	ng	ng	PROPN
ct-9450	43	142	/	/	SYM
ct-9450	43	143	ml	ml	PROPN
ct-9450	43	144	,	,	PUNCT
ct-9450	43	145	respectively	respectively	ADV
ct-9450	43	146	(	(	PUNCT
ct-9450	43	147	mean	mean	PROPN
ct-9450	43	148	±	±	NUM
ct-9450	43	149	sd	sd	NOUN
ct-9450	43	150	)	)	PUNCT
ct-9450	43	151	.	.	PUNCT
ct-9450	44	1	mean	mean	VERB
ct-9450	44	2	pac	pac	PROPN
ct-9450	44	3	for	for	ADP
ct-9450	44	4	treatment	treatment	NOUN
ct-9450	44	5	a	a	PRON
ct-9450	44	6	in	in	ADP
ct-9450	44	7	horses	horse	NOUN
ct-9450	44	8	1	1	NUM
ct-9450	44	9	and	and	CCONJ
ct-9450	44	10	2	2	NUM
ct-9450	44	11	over	over	ADP
ct-9450	44	12	the	the	DET
ct-9450	44	13	trial	trial	NOUN
ct-9450	44	14	period	period	NOUN
ct-9450	44	15	were	be	AUX
ct-9450	44	16	6.56	6.56	NUM
ct-9450	44	17	±	±	NUM
ct-9450	44	18	6.46	6.46	NUM
ct-9450	44	19	and	and	CCONJ
ct-9450	44	20	5.26	5.26	NUM
ct-9450	44	21	±	±	NUM
ct-9450	44	22	4.32	4.32	NUM
ct-9450	44	23	ng	ng	PROPN
ct-9450	44	24	/	/	SYM
ct-9450	44	25	ml	ml	PROPN
ct-9450	45	1	and	and	CCONJ
ct-9450	45	2	for	for	ADP
ct-9450	45	3	treatment	treatment	NOUN
ct-9450	45	4	b	b	NOUN
ct-9450	45	5	in	in	ADP
ct-9450	45	6	horse	horse	NOUN
ct-9450	45	7	1	1	NUM
ct-9450	45	8	and	and	CCONJ
ct-9450	45	9	2	2	NUM
ct-9450	45	10	were	be	AUX
ct-9450	45	11	3.42	3.42	NUM
ct-9450	45	12	±	±	NUM
ct-9450	45	13	0.68	0.68	NUM
ct-9450	45	14	and	and	CCONJ
ct-9450	45	15	0.98	0.98	NUM
ct-9450	45	16	±	±	NUM
ct-9450	45	17	0.09	0.09	NUM
ct-9450	45	18	ng	ng	PROPN
ct-9450	45	19	/	/	SYM
ct-9450	45	20	ml	ml	PROPN
ct-9450	45	21	.	.	PUNCT
ct-9450	45	22	plasma	plasma	PROPN
ct-9450	45	23	altrenogest	altrenogest	NOUN
ct-9450	45	24	concentrations	concentration	NOUN
ct-9450	45	25	in	in	ADP
ct-9450	45	26	treatment	treatment	NOUN
ct-9450	45	27	a	a	PRON
ct-9450	45	28	was	be	AUX
ct-9450	45	29	significantly	significantly	ADV
ct-9450	45	30	higher	high	ADJ
ct-9450	45	31	than	than	ADP
ct-9450	45	32	treatment	treatment	NOUN
ct-9450	45	33	b	b	NOUN
ct-9450	45	34	at	at	ADP
ct-9450	45	35	24	24	NUM
ct-9450	45	36	hours	hour	NOUN
ct-9450	45	37	posttreatment	posttreatment	NOUN
ct-9450	45	38	(	(	PUNCT
ct-9450	45	39	days	day	NOUN
ct-9450	45	40	1	1	NUM
ct-9450	45	41	,	,	PUNCT
ct-9450	45	42	8	8	NUM
ct-9450	45	43	,	,	PUNCT
ct-9450	45	44	and	and	CCONJ
ct-9450	45	45	15	15	NUM
ct-9450	45	46	of	of	ADP
ct-9450	45	47	the	the	DET
ct-9450	45	48	trial	trial	NOUN
ct-9450	45	49	period	period	NOUN
ct-9450	45	50	)	)	PUNCT
ct-9450	45	51	.	.	PUNCT
ct-9450	46	1	posttreatment	posttreatment	NOUN
ct-9450	46	2	,	,	PUNCT
ct-9450	46	3	with	with	ADP
ct-9450	46	4	weekly	weekly	ADJ
ct-9450	46	5	altrenogest	altrenogest	NOUN
ct-9450	46	6	,	,	PUNCT
ct-9450	46	7	pac	pac	PROPN
ct-9450	46	8	markedly	markedly	ADV
ct-9450	46	9	decreased	decrease	VERB
ct-9450	46	10	between	between	ADP
ct-9450	46	11	days	day	NOUN
ct-9450	46	12	1	1	NUM
ct-9450	46	13	and	and	CCONJ
ct-9450	46	14	4	4	NUM
ct-9450	46	15	,	,	PUNCT
ct-9450	46	16	and	and	CCONJ
ct-9450	46	17	days	day	NOUN
ct-9450	46	18	4	4	NUM
ct-9450	46	19	and	and	CCONJ
ct-9450	46	20	7	7	NUM
ct-9450	46	21	over	over	ADP
ct-9450	46	22	each	each	DET
ct-9450	46	23	treatment	treatment	NOUN
ct-9450	46	24	week	week	NOUN
ct-9450	46	25	(	(	PUNCT
ct-9450	46	26	figure	figure	NOUN
ct-9450	46	27	)	)	PUNCT
ct-9450	46	28	.	.	PUNCT
ct-9450	47	1	treatment	treatment	NOUN
ct-9450	47	2	a	a	DET
ct-9450	47	3	treatment	treatment	NOUN
ct-9450	47	4	b	b	NOUN
ct-9450	47	5	-1	-1	NOUN
ct-9450	47	6	0	0	NUM
ct-9450	47	7	1	1	NUM
ct-9450	47	8	2	2	NUM
ct-9450	47	9	3	3	NUM
ct-9450	47	10	4	4	NUM
ct-9450	47	11	5	5	NUM
ct-9450	47	12	6	6	NUM
ct-9450	47	13	7	7	NUM
ct-9450	47	14	8	8	NUM
ct-9450	47	15	9	9	NUM
ct-9450	47	16	10	10	NUM
ct-9450	47	17	11	11	NUM
ct-9450	47	18	12	12	NUM
ct-9450	47	19	13	13	NUM
ct-9450	47	20	14	14	NUM
ct-9450	47	21	15	15	NUM
ct-9450	47	22	16	16	NUM
ct-9450	47	23	17	17	NUM
ct-9450	47	24	18	18	NUM
ct-9450	47	25	19	19	NUM
ct-9450	47	26	20	20	NUM
ct-9450	47	27	21	21	NUM
ct-9450	47	28	22	22	NUM
ct-9450	47	29	day	day	NOUN
ct-9450	47	30	-2	-2	NOUN
ct-9450	47	31	0	0	NUM
ct-9450	47	32	2	2	NUM
ct-9450	47	33	4	4	NUM
ct-9450	47	34	6	6	NUM
ct-9450	47	35	8	8	NUM
ct-9450	47	36	10	10	NUM
ct-9450	47	37	12	12	NUM
ct-9450	47	38	14	14	NUM
ct-9450	47	39	al	al	PROPN
ct-9450	47	40	tre	tre	PROPN
ct-9450	47	41	no	no	DET
ct-9450	47	42	ge	ge	PROPN
ct-9450	47	43	st	st	PROPN
ct-9450	47	44	(	(	PUNCT
ct-9450	47	45	n	n	CCONJ
ct-9450	47	46	g/	g/	NOUN
ct-9450	47	47	m	m	NOUN
ct-9450	47	48	l	l	NOUN
ct-9450	47	49	)	)	PUNCT
ct-9450	47	50	injection	injection	NOUN
ct-9450	47	51	injection	injection	NOUN
ct-9450	47	52	injection	injection	NOUN
ct-9450	47	53	figure	figure	NOUN
ct-9450	47	54	.	.	PUNCT
ct-9450	48	1	mean	mean	VERB
ct-9450	48	2	plasma	plasma	NOUN
ct-9450	48	3	altrenogest	altrenogest	NOUN
ct-9450	48	4	concentrations	concentration	NOUN
ct-9450	48	5	over	over	ADP
ct-9450	48	6	the	the	DET
ct-9450	48	7	3	3	NUM
ct-9450	48	8	-	-	PUNCT
ct-9450	48	9	week	week	NOUN
ct-9450	48	10	period	period	NOUN
ct-9450	48	11	.	.	PUNCT
ct-9450	49	1	treatment	treatment	NOUN
ct-9450	50	1	a	a	DET
ct-9450	50	2	:	:	PUNCT
ct-9450	50	3	intramuscular	intramuscular	ADJ
ct-9450	50	4	altrenogest	altrenog	ADJ
ct-9450	50	5	treatment	treatment	NOUN
ct-9450	50	6	(	(	PUNCT
ct-9450	50	7	injection	injection	NOUN
ct-9450	50	8	)	)	PUNCT
ct-9450	50	9	once	once	ADV
ct-9450	50	10	weekly	weekly	ADJ
ct-9450	50	11	on	on	ADP
ct-9450	50	12	days	day	NOUN
ct-9450	50	13	0	0	NUM
ct-9450	50	14	,	,	PUNCT
ct-9450	50	15	7	7	NUM
ct-9450	50	16	,	,	PUNCT
ct-9450	50	17	and	and	CCONJ
ct-9450	50	18	14	14	NUM
ct-9450	50	19	.	.	PUNCT
ct-9450	51	1	treatment	treatment	NOUN
ct-9450	51	2	b	b	PROPN
ct-9450	51	3	:	:	PUNCT
ct-9450	51	4	oral	oral	ADJ
ct-9450	51	5	altrenogest	altrenogest	NOUN
ct-9450	51	6	treatment	treatment	NOUN
ct-9450	51	7	once	once	ADV
ct-9450	51	8	daily	daily	ADV
ct-9450	51	9	for	for	ADP
ct-9450	51	10	21	21	NUM
ct-9450	51	11	days	day	NOUN
ct-9450	51	12	.	.	PUNCT
ct-9450	52	1	mean	mean	VERB
ct-9450	52	2	pac	pac	PROPN
ct-9450	52	3	from	from	ADP
ct-9450	52	4	treatment	treatment	NOUN
ct-9450	52	5	a	a	PRON
ct-9450	52	6	was	be	AUX
ct-9450	52	7	greater	great	ADJ
ct-9450	52	8	than	than	ADP
ct-9450	52	9	that	that	PRON
ct-9450	52	10	of	of	ADP
ct-9450	52	11	treatment	treatment	NOUN
ct-9450	52	12	b	b	PROPN
ct-9450	52	13	on	on	ADP
ct-9450	52	14	day	day	NOUN
ct-9450	52	15	4	4	NUM
ct-9450	52	16	(	(	PUNCT
ct-9450	52	17	3.48	3.48	NUM
ct-9450	52	18	±	±	NUM
ct-9450	52	19	0.72	0.72	NUM
ct-9450	52	20	and	and	CCONJ
ct-9450	52	21	2.29	2.29	NUM
ct-9450	52	22	±	±	NUM
ct-9450	52	23	1.5	1.5	NUM
ct-9450	52	24	ng	ng	NOUN
ct-9450	52	25	/	/	SYM
ct-9450	52	26	ml	ml	PROPN
ct-9450	52	27	,	,	PUNCT
ct-9450	52	28	respectively	respectively	ADV
ct-9450	52	29	)	)	PUNCT
ct-9450	52	30	.	.	PUNCT
ct-9450	53	1	by	by	ADP
ct-9450	53	2	day	day	NOUN
ct-9450	53	3	7	7	NUM
ct-9450	53	4	of	of	ADP
ct-9450	53	5	each	each	DET
ct-9450	53	6	week	week	NOUN
ct-9450	53	7	,	,	PUNCT
ct-9450	53	8	mean	mean	VERB
ct-9450	53	9	pac	pac	PROPN
ct-9450	53	10	of	of	ADP
ct-9450	53	11	treatment	treatment	NOUN
ct-9450	53	12	a	a	PRON
ct-9450	53	13	were	be	AUX
ct-9450	53	14	below	below	ADP
ct-9450	53	15	treatment	treatment	NOUN
ct-9450	53	16	b	b	PROPN
ct-9450	53	17	(	(	PUNCT
ct-9450	53	18	1.51	1.51	NUM
ct-9450	53	19	±	±	NUM
ct-9450	53	20	0.65	0.65	NUM
ct-9450	53	21	and	and	CCONJ
ct-9450	53	22	2.38	2.38	NUM
ct-9450	53	23	±	±	NUM
ct-9450	53	24	1.53	1.53	NUM
ct-9450	53	25	ng	ng	PROPN
ct-9450	53	26	/	/	SYM
ct-9450	53	27	ml	ml	PROPN
ct-9450	53	28	)	)	PUNCT
ct-9450	53	29	.	.	PUNCT
ct-9450	54	1	no	no	DET
ct-9450	54	2	significant	significant	ADJ
ct-9450	54	3	difference	difference	NOUN
ct-9450	54	4	between	between	ADP
ct-9450	54	5	pac	pac	PROPN
ct-9450	54	6	of	of	ADP
ct-9450	54	7	selected	select	VERB
ct-9450	54	8	preparations	preparation	NOUN
ct-9450	54	9	was	be	AUX
ct-9450	54	10	detected	detect	VERB
ct-9450	54	11	on	on	ADP
ct-9450	54	12	days	day	NOUN
ct-9450	54	13	4	4	NUM
ct-9450	54	14	or	or	CCONJ
ct-9450	54	15	7	7	NUM
ct-9450	54	16	of	of	ADP
ct-9450	54	17	each	each	DET
ct-9450	54	18	week	week	NOUN
ct-9450	54	19	.	.	PUNCT
ct-9450	55	1	discussion	discussion	NOUN
ct-9450	55	2	injectable	injectable	PROPN
ct-9450	55	3	alternogest	alternogest	ADV
ct-9450	55	4	resulted	result	VERB
ct-9450	55	5	in	in	ADP
ct-9450	55	6	an	an	DET
ct-9450	55	7	immediate	immediate	ADJ
ct-9450	55	8	increase	increase	NOUN
ct-9450	55	9	in	in	ADP
ct-9450	55	10	pac	pac	PROPN
ct-9450	55	11	>	>	X
ct-9450	55	12	10	10	NUM
ct-9450	55	13	ng	ng	PROPN
ct-9450	55	14	/	/	SYM
ct-9450	55	15	ml	ml	NOUN
ct-9450	55	16	at	at	ADP
ct-9450	55	17	24	24	NUM
ct-9450	55	18	hours	hour	NOUN
ct-9450	55	19	after	after	ADP
ct-9450	55	20	treatment	treatment	NOUN
ct-9450	55	21	.	.	PUNCT
ct-9450	56	1	by	by	ADP
ct-9450	56	2	4	4	NUM
ct-9450	56	3	days	day	NOUN
ct-9450	56	4	posttreatment	posttreatment	NOUN
ct-9450	56	5	,	,	PUNCT
ct-9450	56	6	pac	pac	PROPN
ct-9450	56	7	markedly	markedly	ADV
ct-9450	56	8	decreased	decrease	VERB
ct-9450	56	9	and	and	CCONJ
ct-9450	56	10	were	be	AUX
ct-9450	56	11	>	>	X
ct-9450	56	12	2	2	NUM
ct-9450	56	13	ng	ng	PROPN
ct-9450	56	14	/	/	SYM
ct-9450	56	15	ml	ml	PROPN
ct-9450	56	16	.	.	PUNCT
ct-9450	57	1	mean	mean	PROPN
ct-9450	57	2	pac	pac	PROPN
ct-9450	57	3	were	be	AUX
ct-9450	57	4	higher	high	ADJ
ct-9450	57	5	for	for	ADP
ct-9450	57	6	a	a	DET
ct-9450	57	7	minimum	minimum	NOUN
ct-9450	57	8	of	of	ADP
ct-9450	57	9	4	4	NUM
ct-9450	57	10	days	day	NOUN
ct-9450	57	11	in	in	ADP
ct-9450	57	12	injectable	injectable	ADJ
ct-9450	57	13	altrenogest	altrenogest	NOUN
ct-9450	57	14	compared	compare	VERB
ct-9450	57	15	to	to	ADP
ct-9450	57	16	oral	oral	ADJ
ct-9450	57	17	altrenogest	altrenogest	NOUN
ct-9450	57	18	.	.	PUNCT
ct-9450	58	1	on	on	ADP
ct-9450	58	2	day	day	NOUN
ct-9450	58	3	7	7	NUM
ct-9450	58	4	of	of	ADP
ct-9450	58	5	each	each	DET
ct-9450	58	6	week	week	NOUN
ct-9450	58	7	,	,	PUNCT
ct-9450	58	8	pac	pac	PROPN
ct-9450	58	9	of	of	ADP
ct-9450	58	10	injectable	injectable	ADJ
ct-9450	58	11	altrenogest	altrenogest	NOUN
ct-9450	58	12	were	be	AUX
ct-9450	58	13	lower	low	ADJ
ct-9450	58	14	than	than	ADP
ct-9450	58	15	oral	oral	ADJ
ct-9450	58	16	altrenogest	altrenogest	NOUN
ct-9450	58	17	(	(	PUNCT
ct-9450	58	18	1.51	1.51	NUM
ct-9450	58	19	±	±	NUM
ct-9450	58	20	0.65	0.65	NUM
ct-9450	58	21	and	and	CCONJ
ct-9450	58	22	2.38	2.38	NUM
ct-9450	58	23	±	±	NUM
ct-9450	58	24	1.53	1.53	NUM
ct-9450	58	25	ng	ng	PROPN
ct-9450	58	26	/	/	SYM
ct-9450	58	27	ml	ml	PROPN
ct-9450	58	28	,	,	PUNCT
ct-9450	58	29	respectively	respectively	ADV
ct-9450	58	30	)	)	PUNCT
ct-9450	58	31	.	.	PUNCT
ct-9450	59	1	similar	similar	ADJ
ct-9450	59	2	results	result	NOUN
ct-9450	59	3	were	be	AUX
ct-9450	59	4	observed	observe	VERB
ct-9450	59	5	when	when	SCONJ
ct-9450	59	6	weekly	weekly	ADJ
ct-9450	59	7	injectable	injectable	ADJ
ct-9450	59	8	altrenogest	altrenogest	NOUN
ct-9450	59	9	(	(	PUNCT
ct-9450	59	10	readyserve	readyserve	VERB
ct-9450	59	11	®	®	NOUN
ct-9450	59	12	150	150	NUM
ct-9450	59	13	mg	mg	NUM
ct-9450	59	14	/	/	SYM
ct-9450	59	15	week	week	NOUN
ct-9450	59	16	)	)	PUNCT
ct-9450	59	17	was	be	AUX
ct-9450	59	18	used.12	used.12	INTJ
ct-9450	60	1	mean	mean	NOUN
ct-9450	60	2	pac	pac	PROPN
ct-9450	60	3	were	be	AUX
ct-9450	60	4	highest	high	ADJ
ct-9450	60	5	~	~	PUNCT
ct-9450	60	6	24	24	NUM
ct-9450	60	7	hours	hour	NOUN
ct-9450	60	8	after	after	ADP
ct-9450	60	9	treatment	treatment	NOUN
ct-9450	60	10	and	and	CCONJ
ct-9450	60	11	were	be	AUX
ct-9450	60	12	>	>	X
ct-9450	60	13	1	1	NUM
ct-9450	60	14	ng	ng	PROPN
ct-9450	60	15	/	/	SYM
ct-9450	60	16	ml	ml	NOUN
ct-9450	60	17	on	on	ADP
ct-9450	60	18	day	day	NOUN
ct-9450	60	19	4	4	NUM
ct-9450	60	20	and	and	CCONJ
ct-9450	60	21	<	<	X
ct-9450	60	22	0.5	0.5	NUM
ct-9450	60	23	ng	ng	PROPN
ct-9450	60	24	/	/	SYM
ct-9450	60	25	ml	ml	NOUN
ct-9450	60	26	at	at	ADP
ct-9450	60	27	6.2	6.2	NUM
ct-9450	60	28	days	day	NOUN
ct-9450	60	29	(	(	PUNCT
ct-9450	60	30	148h	148h	PROPN
ct-9450	60	31	)	)	PUNCT
ct-9450	60	32	.	.	PUNCT
ct-9450	61	1	an	an	DET
ct-9450	61	2	in	in	ADP
ct-9450	61	3	vivo	vivo	ADJ
ct-9450	61	4	assessment	assessment	NOUN
ct-9450	61	5	of	of	ADP
ct-9450	61	6	readyserve	readyserve	ADJ
ct-9450	61	7	®	®	NOUN
ct-9450	61	8	at	at	ADP
ct-9450	61	9	the	the	DET
ct-9450	61	10	same	same	ADJ
ct-9450	61	11	dosage	dosage	NOUN
ct-9450	61	12	used	use	VERB
ct-9450	61	13	in	in	ADP
ct-9450	61	14	this	this	DET
ct-9450	61	15	study	study	NOUN
ct-9450	61	16	was	be	AUX
ct-9450	61	17	not	not	PART
ct-9450	61	18	reliable	reliable	ADJ
ct-9450	61	19	in	in	ADP
ct-9450	61	20	supressing	supresse	VERB
ct-9450	61	21	estrus	estrus	NOUN
ct-9450	61	22	in	in	ADP
ct-9450	61	23	all	all	DET
ct-9450	61	24	mares	mare	NOUN
ct-9450	61	25	for	for	ADP
ct-9450	61	26	the	the	DET
ct-9450	61	27	full	full	ADJ
ct-9450	61	28	7	7	NUM
ct-9450	61	29	-	-	PUNCT
ct-9450	61	30	day	day	NOUN
ct-9450	61	31	treatment	treatment	NOUN
ct-9450	61	32	window	window	NOUN
ct-9450	61	33	.	.	PUNCT
ct-9450	62	1	comparable	comparable	ADJ
ct-9450	62	2	to	to	ADP
ct-9450	62	3	this	this	PRON
ct-9450	62	4	,	,	PUNCT
ct-9450	62	5	our	our	PRON
ct-9450	62	6	findings	finding	NOUN
ct-9450	62	7	indicated	indicate	VERB
ct-9450	62	8	that	that	SCONJ
ct-9450	62	9	concentrations	concentration	NOUN
ct-9450	62	10	associated	associate	VERB
ct-9450	62	11	with	with	ADP
ct-9450	62	12	injectable	injectable	ADJ
ct-9450	62	13	altrenogest	altrenog	ADJ
ct-9450	62	14	preparations	preparation	NOUN
ct-9450	62	15	were	be	AUX
ct-9450	62	16	higher	high	ADJ
ct-9450	62	17	than	than	ADP
ct-9450	62	18	oral	oral	ADJ
ct-9450	62	19	altrenogest	altrenogest	NOUN
ct-9450	62	20	for	for	ADP
ct-9450	62	21	4	4	NUM
ct-9450	62	22	days	day	NOUN
ct-9450	62	23	,	,	PUNCT
ct-9450	62	24	but	but	CCONJ
ct-9450	62	25	may	may	AUX
ct-9450	62	26	not	not	PART
ct-9450	62	27	effective	effective	VERB
ct-9450	62	28	between	between	ADP
ct-9450	62	29	days	day	NOUN
ct-9450	62	30	5	5	NUM
ct-9450	62	31	and	and	CCONJ
ct-9450	62	32	7	7	NUM
ct-9450	62	33	posttreatment	posttreatment	NOUN
ct-9450	62	34	in	in	ADP
ct-9450	62	35	mares	mare	NOUN
ct-9450	62	36	.	.	PUNCT
ct-9450	63	1	other	other	ADJ
ct-9450	63	2	injectable	injectable	ADJ
ct-9450	63	3	altrenogest	altrenogest	NOUN
ct-9450	63	4	,	,	PUNCT
ct-9450	63	5	not	not	PART
ct-9450	63	6	readily	readily	ADV
ct-9450	63	7	available	available	ADJ
ct-9450	63	8	in	in	ADP
ct-9450	63	9	australia	australia	PROPN
ct-9450	63	10	,	,	PUNCT
ct-9450	63	11	have	have	AUX
ct-9450	63	12	been	be	AUX
ct-9450	63	13	successful	successful	ADJ
ct-9450	63	14	in	in	ADP
ct-9450	63	15	suppressing	suppress	VERB
ct-9450	63	16	estrus	estrus	NOUN
ct-9450	63	17	and	and	CCONJ
ct-9450	63	18	ovulation	ovulation	NOUN
ct-9450	63	19	in	in	ADP
ct-9450	63	20	mares	mare	NOUN
ct-9450	63	21	treated	treat	VERB
ct-9450	63	22	for	for	ADP
ct-9450	63	23	up	up	ADP
ct-9450	63	24	to	to	PART
ct-9450	63	25	33	33	NUM
ct-9450	63	26	clinical	clinical	ADJ
ct-9450	63	27	theriogenology	theriogenology	NOUN
ct-9450	64	1	•	•	NOUN
ct-9450	65	1	volume	volume	NOUN
ct-9450	65	2	12	12	NUM
ct-9450	65	3	number	number	NOUN
ct-9450	65	4	4	4	NUM
ct-9450	65	5	•	•	NOUN
ct-9450	65	6	december	december	PROPN
ct-9450	65	7	2020513	2020513	NUM
ct-9450	65	8	days.10	days.10	NOUN
ct-9450	65	9	however	however	ADV
ct-9450	65	10	,	,	PUNCT
ct-9450	65	11	the	the	DET
ct-9450	65	12	recommended	recommend	VERB
ct-9450	65	13	dosage	dosage	NOUN
ct-9450	65	14	is	be	AUX
ct-9450	65	15	1.5	1.5	NUM
ct-9450	65	16	3.3	3.3	NUM
ct-9450	65	17	times	time	NOUN
ct-9450	65	18	higher	high	ADJ
ct-9450	65	19	than	than	ADP
ct-9450	65	20	the	the	DET
ct-9450	65	21	dosage	dosage	NOUN
ct-9450	65	22	used	use	VERB
ct-9450	65	23	in	in	ADP
ct-9450	65	24	our	our	PRON
ct-9450	65	25	study	study	NOUN
ct-9450	65	26	.	.	PUNCT
ct-9450	66	1	therefore	therefore	ADV
ct-9450	66	2	,	,	PUNCT
ct-9450	66	3	further	further	ADJ
ct-9450	66	4	investigation	investigation	NOUN
ct-9450	66	5	with	with	ADP
ct-9450	66	6	increased	increase	VERB
ct-9450	66	7	dosing	dose	VERB
ct-9450	66	8	regimens	regimen	NOUN
ct-9450	66	9	would	would	AUX
ct-9450	66	10	be	be	AUX
ct-9450	66	11	beneficial	beneficial	ADJ
ct-9450	66	12	,	,	PUNCT
ct-9450	66	13	as	as	SCONJ
ct-9450	66	14	it	it	PRON
ct-9450	66	15	may	may	AUX
ct-9450	66	16	result	result	VERB
ct-9450	66	17	in	in	ADP
ct-9450	66	18	higher	high	ADJ
ct-9450	66	19	pac	pac	PROPN
ct-9450	66	20	,	,	PUNCT
ct-9450	66	21	more	more	ADV
ct-9450	66	22	effective	effective	ADJ
ct-9450	66	23	suppression	suppression	NOUN
ct-9450	66	24	of	of	ADP
ct-9450	66	25	estrus	estrus	NOUN
ct-9450	66	26	and	and	CCONJ
ct-9450	66	27	reduced	reduce	VERB
ct-9450	66	28	frequency	frequency	NOUN
ct-9450	66	29	of	of	ADP
ct-9450	66	30	treatments	treatment	NOUN
ct-9450	66	31	,	,	PUNCT
ct-9450	66	32	thereby	thereby	ADV
ct-9450	66	33	minimising	minimise	VERB
ct-9450	66	34	human	human	ADJ
ct-9450	66	35	contact	contact	NOUN
ct-9450	66	36	and	and	CCONJ
ct-9450	66	37	associated	associated	ADJ
ct-9450	66	38	risks	risk	NOUN
ct-9450	66	39	.	.	PUNCT
ct-9450	67	1	for	for	ADP
ct-9450	67	2	both	both	DET
ct-9450	67	3	treatments	treatment	NOUN
ct-9450	67	4	,	,	PUNCT
ct-9450	67	5	horse	horse	NOUN
ct-9450	67	6	1	1	NUM
ct-9450	67	7	had	have	VERB
ct-9450	67	8	higher	high	ADJ
ct-9450	67	9	pac	pac	NOUN
ct-9450	67	10	than	than	ADP
ct-9450	67	11	horse	horse	NOUN
ct-9450	67	12	2	2	NUM
ct-9450	67	13	.	.	PUNCT
ct-9450	68	1	interestingly	interestingly	ADV
ct-9450	68	2	,	,	PUNCT
ct-9450	68	3	horse	horse	NOUN
ct-9450	68	4	1	1	NUM
ct-9450	68	5	was	be	AUX
ct-9450	68	6	considered	consider	VERB
ct-9450	68	7	a	a	DET
ct-9450	68	8	body	body	NOUN
ct-9450	68	9	condition	condition	NOUN
ct-9450	68	10	(	(	PUNCT
ct-9450	68	11	fatness	fatness	NOUN
ct-9450	68	12	)	)	PUNCT
ct-9450	68	13	score	score	NOUN
ct-9450	68	14	of	of	ADP
ct-9450	68	15	2	2	NUM
ct-9450	68	16	(	(	PUNCT
ct-9450	68	17	thin	thin	ADJ
ct-9450	68	18	)	)	PUNCT
ct-9450	68	19	,	,	PUNCT
ct-9450	68	20	whereas	whereas	SCONJ
ct-9450	68	21	horse	horse	NOUN
ct-9450	68	22	2	2	NUM
ct-9450	68	23	was	be	AUX
ct-9450	68	24	considered	consider	VERB
ct-9450	68	25	a	a	DET
ct-9450	68	26	body	body	NOUN
ct-9450	68	27	condition	condition	NOUN
ct-9450	68	28	score	score	NOUN
ct-9450	68	29	of	of	ADP
ct-9450	68	30	4	4	NUM
ct-9450	68	31	(	(	PUNCT
ct-9450	68	32	fat	fat	NOUN
ct-9450	68	33	)	)	PUNCT
ct-9450	68	34	on	on	ADP
ct-9450	68	35	a	a	DET
ct-9450	68	36	scale	scale	NOUN
ct-9450	68	37	of	of	ADP
ct-9450	68	38	0	0	NUM
ct-9450	68	39	to	to	PART
ct-9450	68	40	5	5	NUM
ct-9450	68	41	.	.	PUNCT
ct-9450	69	1	altrenogest	altrenogest	PROPN
ct-9450	69	2	was	be	AUX
ct-9450	69	3	detected	detect	VERB
ct-9450	69	4	in	in	ADP
ct-9450	69	5	liver	liver	NOUN
ct-9450	69	6	,	,	PUNCT
ct-9450	69	7	fat	fat	NOUN
ct-9450	69	8	,	,	PUNCT
ct-9450	69	9	kidneys	kidney	NOUN
ct-9450	69	10	and	and	CCONJ
ct-9450	69	11	muscle	muscle	NOUN
ct-9450	69	12	after	after	ADP
ct-9450	69	13	treatment	treatment	NOUN
ct-9450	69	14	.	.	PUNCT
ct-9450	70	1	liver	liver	NOUN
ct-9450	70	2	had	have	VERB
ct-9450	70	3	the	the	DET
ct-9450	70	4	highest	high	ADJ
ct-9450	70	5	tissue	tissue	NOUN
ct-9450	70	6	concentrations	concentration	NOUN
ct-9450	70	7	of	of	ADP
ct-9450	70	8	altrenogest	altrenogest	NOUN
ct-9450	70	9	posttreatment	posttreatment	NOUN
ct-9450	70	10	,	,	PUNCT
ct-9450	70	11	followed	follow	VERB
ct-9450	70	12	by	by	ADP
ct-9450	70	13	fat.13	fat.13	NOUN
ct-9450	70	14	to	to	ADP
ct-9450	70	15	date	date	NOUN
ct-9450	70	16	,	,	PUNCT
ct-9450	70	17	there	there	PRON
ct-9450	70	18	are	be	VERB
ct-9450	70	19	no	no	DET
ct-9450	70	20	studies	study	NOUN
ct-9450	70	21	in	in	ADP
ct-9450	70	22	horses	horse	NOUN
ct-9450	70	23	that	that	PRON
ct-9450	70	24	indicated	indicate	VERB
ct-9450	70	25	whether	whether	SCONJ
ct-9450	70	26	high	high	ADJ
ct-9450	70	27	body	body	NOUN
ct-9450	70	28	condition	condition	NOUN
ct-9450	70	29	influenced	influence	VERB
ct-9450	70	30	circulating	circulate	VERB
ct-9450	70	31	plasma	plasma	NOUN
ct-9450	70	32	concentrations	concentration	NOUN
ct-9450	70	33	of	of	ADP
ct-9450	70	34	progestogens	progestogen	NOUN
ct-9450	70	35	.	.	PUNCT
ct-9450	71	1	however	however	ADV
ct-9450	71	2	,	,	PUNCT
ct-9450	71	3	an	an	DET
ct-9450	71	4	influence	influence	NOUN
ct-9450	71	5	was	be	AUX
ct-9450	71	6	noted	note	VERB
ct-9450	71	7	in	in	ADP
ct-9450	71	8	cattle	cattle	NOUN
ct-9450	71	9	,	,	PUNCT
ct-9450	71	10	rats	rat	NOUN
ct-9450	71	11	and	and	CCONJ
ct-9450	71	12	humans.14	humans.14	NOUN
ct-9450	71	13	-	-	PUNCT
ct-9450	71	14	16	16	NUM
ct-9450	71	15	a	a	DET
ct-9450	71	16	horse	horse	NOUN
ct-9450	71	17	’s	’s	PART
ct-9450	71	18	body	body	NOUN
ct-9450	71	19	condition	condition	NOUN
ct-9450	71	20	could	could	AUX
ct-9450	71	21	influence	influence	VERB
ct-9450	71	22	circulating	circulate	VERB
ct-9450	71	23	plasma	plasma	NOUN
ct-9450	71	24	concentrations	concentration	NOUN
ct-9450	71	25	,	,	PUNCT
ct-9450	71	26	particularly	particularly	ADV
ct-9450	71	27	if	if	SCONJ
ct-9450	71	28	altrenogest	altrenogest	NOUN
ct-9450	71	29	is	be	AUX
ct-9450	71	30	deposited	deposit	VERB
ct-9450	71	31	in	in	ADP
ct-9450	71	32	fat	fat	NOUN
ct-9450	71	33	.	.	PUNCT
ct-9450	72	1	as	as	SCONJ
ct-9450	72	2	altrenogest	altrenog	ADJ
ct-9450	72	3	is	be	AUX
ct-9450	72	4	marketed	market	VERB
ct-9450	72	5	with	with	ADP
ct-9450	72	6	a	a	DET
ct-9450	72	7	weightdependent	weightdependent	ADJ
ct-9450	72	8	dosage	dosage	NOUN
ct-9450	72	9	,	,	PUNCT
ct-9450	72	10	further	further	ADJ
ct-9450	72	11	research	research	NOUN
ct-9450	72	12	is	be	AUX
ct-9450	72	13	warranted	warrant	VERB
ct-9450	72	14	to	to	PART
ct-9450	72	15	ensure	ensure	VERB
ct-9450	72	16	that	that	SCONJ
ct-9450	72	17	body	body	NOUN
ct-9450	72	18	condition	condition	NOUN
ct-9450	72	19	does	do	AUX
ct-9450	72	20	not	not	PART
ct-9450	72	21	adversely	adversely	ADV
ct-9450	72	22	influence	influence	VERB
ct-9450	72	23	altrenogest	altrenog	ADJ
ct-9450	72	24	efficacy	efficacy	PROPN
ct-9450	72	25	.	.	PUNCT
ct-9450	73	1	during	during	ADP
ct-9450	73	2	the	the	DET
ct-9450	73	3	3	3	NUM
ct-9450	73	4	-	-	PUNCT
ct-9450	73	5	week	week	NOUN
ct-9450	73	6	trial	trial	NOUN
ct-9450	73	7	period	period	NOUN
ct-9450	73	8	,	,	PUNCT
ct-9450	73	9	mean	mean	VERB
ct-9450	73	10	minimum	minimum	ADJ
ct-9450	73	11	concentrations	concentration	NOUN
ct-9450	73	12	of	of	ADP
ct-9450	73	13	altrenogest	altrenogest	NOUN
ct-9450	73	14	for	for	SCONJ
ct-9450	73	15	both	both	DET
ct-9450	73	16	preparations	preparation	NOUN
ct-9450	73	17	had	have	VERB
ct-9450	73	18	an	an	DET
ct-9450	73	19	increasing	increase	VERB
ct-9450	73	20	trend	trend	NOUN
ct-9450	73	21	.	.	PUNCT
ct-9450	74	1	at	at	ADP
ct-9450	74	2	the	the	DET
ct-9450	74	3	end	end	NOUN
ct-9450	74	4	of	of	ADP
ct-9450	74	5	the	the	DET
ct-9450	74	6	first	first	ADJ
ct-9450	74	7	full	full	ADJ
ct-9450	74	8	treatment	treatment	NOUN
ct-9450	74	9	period	period	NOUN
ct-9450	74	10	for	for	ADP
ct-9450	74	11	each	each	DET
ct-9450	74	12	preparation	preparation	NOUN
ct-9450	74	13	,	,	PUNCT
ct-9450	74	14	(	(	PUNCT
ct-9450	74	15	7	7	NUM
ct-9450	74	16	days	day	NOUN
ct-9450	74	17	for	for	ADP
ct-9450	74	18	injectable	injectable	NOUN
ct-9450	74	19	and	and	CCONJ
ct-9450	74	20	24	24	NUM
ct-9450	74	21	hours	hour	NOUN
ct-9450	74	22	for	for	ADP
ct-9450	74	23	oral	oral	ADJ
ct-9450	74	24	)	)	PUNCT
ct-9450	74	25	,	,	PUNCT
ct-9450	74	26	mean	mean	VERB
ct-9450	74	27	minimum	minimum	ADJ
ct-9450	74	28	concentrations	concentration	NOUN
ct-9450	74	29	for	for	ADP
ct-9450	74	30	treatments	treatment	NOUN
ct-9450	74	31	a	a	DET
ct-9450	74	32	and	and	CCONJ
ct-9450	74	33	b	b	NOUN
ct-9450	74	34	were	be	AUX
ct-9450	74	35	0.92	0.92	NUM
ct-9450	74	36	and	and	CCONJ
ct-9450	74	37	1.38	1.38	NUM
ct-9450	74	38	ng	ng	PROPN
ct-9450	74	39	/	/	SYM
ct-9450	74	40	ml	ml	PROPN
ct-9450	74	41	,	,	PUNCT
ct-9450	74	42	respectively	respectively	ADV
ct-9450	74	43	.	.	PUNCT
ct-9450	75	1	however	however	ADV
ct-9450	75	2	,	,	PUNCT
ct-9450	75	3	at	at	ADP
ct-9450	75	4	the	the	DET
ct-9450	75	5	end	end	NOUN
ct-9450	75	6	of	of	ADP
ct-9450	75	7	the	the	DET
ct-9450	75	8	3	3	NUM
ct-9450	75	9	-	-	PUNCT
ct-9450	75	10	week	week	NOUN
ct-9450	75	11	trial	trial	NOUN
ct-9450	75	12	period	period	NOUN
ct-9450	75	13	,	,	PUNCT
ct-9450	75	14	mean	mean	VERB
ct-9450	75	15	minimum	minimum	ADJ
ct-9450	75	16	concentrations	concentration	NOUN
ct-9450	75	17	for	for	ADP
ct-9450	75	18	treatment	treatment	NOUN
ct-9450	75	19	a	a	PRON
ct-9450	75	20	and	and	CCONJ
ct-9450	75	21	treatment	treatment	NOUN
ct-9450	75	22	b	b	PROPN
ct-9450	75	23	were	be	AUX
ct-9450	75	24	2.05	2.05	NUM
ct-9450	75	25	and	and	CCONJ
ct-9450	75	26	2.30	2.30	NUM
ct-9450	75	27	ng	ng	PROPN
ct-9450	75	28	/	/	SYM
ct-9450	75	29	ml	ml	PROPN
ct-9450	75	30	,	,	PUNCT
ct-9450	75	31	respectively	respectively	ADV
ct-9450	75	32	.	.	PUNCT
ct-9450	76	1	although	although	SCONJ
ct-9450	76	2	our	our	PRON
ct-9450	76	3	sample	sample	NOUN
ct-9450	76	4	size	size	NOUN
ct-9450	76	5	was	be	AUX
ct-9450	76	6	not	not	PART
ct-9450	76	7	large	large	ADJ
ct-9450	76	8	enough	enough	ADV
ct-9450	76	9	to	to	PART
ct-9450	76	10	identify	identify	VERB
ct-9450	76	11	a	a	DET
ct-9450	76	12	significant	significant	ADJ
ct-9450	76	13	difference	difference	NOUN
ct-9450	76	14	,	,	PUNCT
ct-9450	76	15	this	this	DET
ct-9450	76	16	observation	observation	NOUN
ct-9450	76	17	may	may	AUX
ct-9450	76	18	be	be	AUX
ct-9450	76	19	an	an	DET
ct-9450	76	20	indication	indication	NOUN
ct-9450	76	21	of	of	ADP
ct-9450	76	22	a	a	DET
ct-9450	76	23	cumulative	cumulative	ADJ
ct-9450	76	24	effect	effect	NOUN
ct-9450	76	25	worthy	worthy	ADJ
ct-9450	76	26	of	of	ADP
ct-9450	76	27	further	further	ADJ
ct-9450	76	28	research	research	NOUN
ct-9450	76	29	.	.	PUNCT
ct-9450	77	1	a	a	DET
ct-9450	77	2	cumulative	cumulative	ADJ
ct-9450	77	3	effect	effect	NOUN
ct-9450	77	4	following	follow	VERB
ct-9450	77	5	long	long	ADJ
ct-9450	77	6	-	-	PUNCT
ct-9450	77	7	term	term	NOUN
ct-9450	77	8	altrenogest	altrenogest	NOUN
ct-9450	77	9	has	have	AUX
ct-9450	77	10	not	not	PART
ct-9450	77	11	been	be	AUX
ct-9450	77	12	reported	report	VERB
ct-9450	77	13	in	in	ADP
ct-9450	77	14	horses	horse	NOUN
ct-9450	77	15	.	.	PUNCT
ct-9450	78	1	however	however	ADV
ct-9450	78	2	,	,	PUNCT
ct-9450	78	3	during	during	ADP
ct-9450	78	4	prolonged	prolonged	ADJ
ct-9450	78	5	altrenogest	altrenogest	NOUN
ct-9450	78	6	treatment	treatment	NOUN
ct-9450	78	7	in	in	ADP
ct-9450	78	8	pigs	pig	NOUN
ct-9450	78	9	,	,	PUNCT
ct-9450	78	10	an	an	DET
ct-9450	78	11	accumulation	accumulation	NOUN
ct-9450	78	12	in	in	ADP
ct-9450	78	13	blood	blood	NOUN
ct-9450	78	14	plasma	plasma	NOUN
ct-9450	78	15	has	have	AUX
ct-9450	78	16	been	be	AUX
ct-9450	78	17	demonstrated.13	demonstrated.13	VERB
ct-9450	78	18	further	further	ADJ
ct-9450	78	19	research	research	NOUN
ct-9450	78	20	into	into	ADP
ct-9450	78	21	the	the	DET
ct-9450	78	22	possibility	possibility	NOUN
ct-9450	78	23	of	of	ADP
ct-9450	78	24	a	a	DET
ct-9450	78	25	cumulative	cumulative	ADJ
ct-9450	78	26	effect	effect	NOUN
ct-9450	78	27	of	of	ADP
ct-9450	78	28	long	long	ADJ
ct-9450	78	29	-	-	PUNCT
ct-9450	78	30	term	term	NOUN
ct-9450	78	31	altrenogest	altrenogest	NOUN
ct-9450	78	32	treatment	treatment	NOUN
ct-9450	78	33	could	could	AUX
ct-9450	78	34	be	be	AUX
ct-9450	78	35	useful	useful	ADJ
ct-9450	78	36	to	to	PART
ct-9450	78	37	determine	determine	VERB
ct-9450	78	38	if	if	SCONJ
ct-9450	78	39	minimum	minimum	ADJ
ct-9450	78	40	concentrations	concentration	NOUN
ct-9450	78	41	of	of	ADP
ct-9450	78	42	a	a	DET
ct-9450	78	43	weekly	weekly	ADJ
ct-9450	78	44	injectable	injectable	ADJ
ct-9450	78	45	preparation	preparation	NOUN
ct-9450	78	46	would	would	AUX
ct-9450	78	47	eventually	eventually	ADV
ct-9450	78	48	maintain	maintain	VERB
ct-9450	78	49	concentrations	concentration	NOUN
ct-9450	78	50	comparable	comparable	ADJ
ct-9450	78	51	to	to	ADP
ct-9450	78	52	a	a	DET
ct-9450	78	53	daily	daily	ADJ
ct-9450	78	54	oral	oral	ADJ
ct-9450	78	55	preparation	preparation	NOUN
ct-9450	78	56	.	.	PUNCT
ct-9450	79	1	there	there	PRON
ct-9450	79	2	were	be	VERB
ct-9450	79	3	several	several	ADJ
ct-9450	79	4	limitations	limitation	NOUN
ct-9450	79	5	associated	associate	VERB
ct-9450	79	6	with	with	ADP
ct-9450	79	7	this	this	DET
ct-9450	79	8	pilot	pilot	NOUN
ct-9450	79	9	study	study	NOUN
ct-9450	79	10	.	.	PUNCT
ct-9450	80	1	a	a	DET
ct-9450	80	2	decision	decision	NOUN
ct-9450	80	3	was	be	AUX
ct-9450	80	4	made	make	VERB
ct-9450	80	5	to	to	PART
ct-9450	80	6	use	use	VERB
ct-9450	80	7	mares	mare	NOUN
ct-9450	80	8	with	with	ADP
ct-9450	80	9	no	no	PRON
ct-9450	80	10	in	in	ADP
ct-9450	80	11	vivo	vivo	ADJ
ct-9450	80	12	source	source	NOUN
ct-9450	80	13	of	of	ADP
ct-9450	80	14	progesterone	progesterone	NOUN
ct-9450	80	15	,	,	PUNCT
ct-9450	80	16	which	which	PRON
ct-9450	80	17	are	be	AUX
ct-9450	80	18	scarcely	scarcely	ADV
ct-9450	80	19	available	available	ADJ
ct-9450	80	20	,	,	PUNCT
ct-9450	80	21	and	and	CCONJ
ct-9450	80	22	resulted	result	VERB
ct-9450	80	23	in	in	ADP
ct-9450	80	24	a	a	DET
ct-9450	80	25	sample	sample	NOUN
ct-9450	80	26	size	size	NOUN
ct-9450	80	27	of	of	ADP
ct-9450	80	28	only	only	ADV
ct-9450	80	29	2	2	NUM
ct-9450	80	30	mares	mare	NOUN
ct-9450	80	31	.	.	PUNCT
ct-9450	81	1	a	a	DET
ct-9450	81	2	larger	large	ADJ
ct-9450	81	3	sample	sample	NOUN
ct-9450	81	4	size	size	NOUN
ct-9450	81	5	would	would	AUX
ct-9450	81	6	have	have	AUX
ct-9450	81	7	provided	provide	VERB
ct-9450	81	8	a	a	DET
ct-9450	81	9	better	well	ADJ
ct-9450	81	10	indication	indication	NOUN
ct-9450	81	11	of	of	ADP
ct-9450	81	12	mean	mean	NOUN
ct-9450	81	13	and	and	CCONJ
ct-9450	81	14	minimum	minimum	NOUN
ct-9450	81	15	pac	pac	PROPN
ct-9450	81	16	after	after	ADP
ct-9450	81	17	treatment	treatment	NOUN
ct-9450	81	18	,	,	PUNCT
ct-9450	81	19	allowing	allow	VERB
ct-9450	81	20	for	for	ADP
ct-9450	81	21	significant	significant	ADJ
ct-9450	81	22	differences	difference	NOUN
ct-9450	81	23	to	to	PART
ct-9450	81	24	be	be	AUX
ct-9450	81	25	discriminated	discriminate	VERB
ct-9450	81	26	.	.	PUNCT
ct-9450	82	1	restrictions	restriction	NOUN
ct-9450	82	2	on	on	ADP
ct-9450	82	3	sampling	sample	VERB
ct-9450	82	4	frequency	frequency	NOUN
ct-9450	82	5	did	do	AUX
ct-9450	82	6	not	not	PART
ct-9450	82	7	allow	allow	VERB
ct-9450	82	8	documentation	documentation	NOUN
ct-9450	82	9	of	of	ADP
ct-9450	82	10	peak	peak	NOUN
ct-9450	82	11	concentrations	concentration	NOUN
ct-9450	82	12	.	.	PUNCT
ct-9450	83	1	however	however	ADV
ct-9450	83	2	,	,	PUNCT
ct-9450	83	3	minimum	minimum	ADJ
ct-9450	83	4	concentrations	concentration	NOUN
ct-9450	83	5	associated	associate	VERB
ct-9450	83	6	with	with	ADP
ct-9450	83	7	both	both	DET
ct-9450	83	8	treatments	treatment	NOUN
ct-9450	83	9	were	be	AUX
ct-9450	83	10	characterized	characterize	VERB
ct-9450	83	11	,	,	PUNCT
ct-9450	83	12	as	as	SCONJ
ct-9450	83	13	sampling	sample	VERB
ct-9450	83	14	occurred	occur	VERB
ct-9450	83	15	immediately	immediately	ADV
ct-9450	83	16	prior	prior	ADV
ct-9450	83	17	to	to	ADP
ct-9450	83	18	treatments	treatment	NOUN
ct-9450	83	19	.	.	PUNCT
ct-9450	84	1	results	result	NOUN
ct-9450	84	2	from	from	ADP
ct-9450	84	3	this	this	DET
ct-9450	84	4	preliminary	preliminary	ADJ
ct-9450	84	5	study	study	NOUN
ct-9450	84	6	characterized	characterize	VERB
ct-9450	84	7	pac	pac	PROPN
ct-9450	84	8	during	during	ADP
ct-9450	84	9	treatment	treatment	NOUN
ct-9450	84	10	and	and	CCONJ
ct-9450	84	11	provided	provide	VERB
ct-9450	84	12	evidence	evidence	NOUN
ct-9450	84	13	that	that	SCONJ
ct-9450	84	14	injectable	injectable	ADJ
ct-9450	84	15	altrenogest	altrenogest	NOUN
ct-9450	84	16	was	be	AUX
ct-9450	84	17	comparable	comparable	ADJ
ct-9450	84	18	to	to	ADP
ct-9450	84	19	daily	daily	ADJ
ct-9450	84	20	oral	oral	ADJ
ct-9450	84	21	altrenogest	altrenogest	NOUN
ct-9450	84	22	for	for	ADP
ct-9450	84	23	a	a	DET
ct-9450	84	24	minimum	minimum	NOUN
ct-9450	84	25	of	of	ADP
ct-9450	84	26	4	4	NUM
ct-9450	84	27	days	day	NOUN
ct-9450	84	28	,	,	PUNCT
ct-9450	84	29	but	but	CCONJ
ct-9450	84	30	may	may	AUX
ct-9450	84	31	not	not	PART
ct-9450	84	32	be	be	AUX
ct-9450	84	33	comparable	comparable	ADJ
ct-9450	84	34	or	or	CCONJ
ct-9450	84	35	effective	effective	ADJ
ct-9450	84	36	between	between	ADP
ct-9450	84	37	days	day	NOUN
ct-9450	84	38	5	5	NUM
ct-9450	84	39	and	and	CCONJ
ct-9450	84	40	7	7	NUM
ct-9450	84	41	posttreatment	posttreatment	NOUN
ct-9450	84	42	.	.	PUNCT
ct-9450	85	1	this	this	PRON
ct-9450	85	2	should	should	AUX
ct-9450	85	3	be	be	AUX
ct-9450	85	4	taken	take	VERB
ct-9450	85	5	into	into	ADP
ct-9450	85	6	consideration	consideration	NOUN
ct-9450	85	7	if	if	SCONJ
ct-9450	85	8	using	use	VERB
ct-9450	85	9	injectable	injectable	ADJ
ct-9450	85	10	altrenogest	altrenogest	NOUN
ct-9450	85	11	as	as	ADP
ct-9450	85	12	a	a	DET
ct-9450	85	13	substitute	substitute	NOUN
ct-9450	85	14	for	for	ADP
ct-9450	85	15	oral	oral	ADJ
ct-9450	85	16	altrenogest	altrenogest	NOUN
ct-9450	85	17	in	in	ADP
ct-9450	85	18	mare	mare	PROPN
ct-9450	85	19	reproductive	reproductive	ADJ
ct-9450	85	20	management	management	NOUN
ct-9450	85	21	,	,	PUNCT
ct-9450	85	22	as	as	SCONJ
ct-9450	85	23	minimum	minimum	NOUN
ct-9450	85	24	target	target	NOUN
ct-9450	85	25	pac	pac	PROPN
ct-9450	85	26	are	be	AUX
ct-9450	85	27	yet	yet	ADV
ct-9450	85	28	to	to	PART
ct-9450	85	29	be	be	AUX
ct-9450	85	30	determined	determine	VERB
ct-9450	85	31	for	for	ADP
ct-9450	85	32	either	either	DET
ct-9450	85	33	pregnancy	pregnancy	NOUN
ct-9450	85	34	management	management	NOUN
ct-9450	85	35	or	or	CCONJ
ct-9450	85	36	estrus	estrus	NOUN
ct-9450	85	37	suppression	suppression	NOUN
ct-9450	85	38	.	.	PUNCT
ct-9450	86	1	further	further	ADJ
ct-9450	86	2	research	research	NOUN
ct-9450	86	3	with	with	ADP
ct-9450	86	4	a	a	DET
ct-9450	86	5	larger	large	ADJ
ct-9450	86	6	number	number	NOUN
ct-9450	86	7	of	of	ADP
ct-9450	86	8	animals	animal	NOUN
ct-9450	86	9	is	be	AUX
ct-9450	86	10	required	require	VERB
ct-9450	86	11	to	to	PART
ct-9450	86	12	determine	determine	VERB
ct-9450	86	13	bioequivalence	bioequivalence	NOUN
ct-9450	86	14	of	of	ADP
ct-9450	86	15	these	these	DET
ct-9450	86	16	2	2	NUM
ct-9450	86	17	preparations	preparation	NOUN
ct-9450	86	18	.	.	PUNCT
ct-9450	87	1	conflict	conflict	NOUN
ct-9450	87	2	of	of	ADP
ct-9450	87	3	interest	interest	NOUN
ct-9450	87	4	none	none	NOUN
ct-9450	87	5	to	to	PART
ct-9450	87	6	declare	declare	VERB
ct-9450	87	7	.	.	PUNCT
ct-9450	88	1	funding	fund	VERB
ct-9450	88	2	randlab	randlab	PROPN
ct-9450	88	3	pty	pty	PROPN
ct-9450	88	4	ltd	ltd	PROPN
ct-9450	88	5	,	,	PUNCT
ct-9450	88	6	chipping	chip	VERB
ct-9450	88	7	norton	norton	NOUN
ct-9450	88	8	,	,	PUNCT
ct-9450	88	9	new	new	ADJ
ct-9450	88	10	south	south	PROPN
ct-9450	88	11	wales	wales	PROPN
ct-9450	88	12	,	,	PUNCT
ct-9450	88	13	australia	australia	PROPN
ct-9450	88	14	.	.	PUNCT
ct-9450	89	1	acknowledgement	acknowledgement	PROPN
ct-9450	89	2	authors	author	NOUN
ct-9450	89	3	thank	thank	VERB
ct-9450	89	4	joe	joe	PROPN
ct-9450	89	5	pippia	pippia	PROPN
ct-9450	89	6	at	at	ADP
ct-9450	89	7	pia	pia	PROPN
ct-9450	89	8	pharma	pharma	PROPN
ct-9450	89	9	for	for	ADP
ct-9450	89	10	hplc	hplc	NOUN
ct-9450	89	11	-	-	PUNCT
ct-9450	89	12	ms	ms	NOUN
ct-9450	89	13	analysis	analysis	NOUN
ct-9450	89	14	and	and	CCONJ
ct-9450	89	15	alex	alex	PROPN
ct-9450	89	16	tinning	tinning	NOUN
ct-9450	89	17	and	and	CCONJ
ct-9450	89	18	kirsten	kirsten	PROPN
ct-9450	89	19	volz	volz	PROPN
ct-9450	89	20	for	for	ADP
ct-9450	89	21	their	their	PRON
ct-9450	89	22	assistance	assistance	NOUN
ct-9450	89	23	in	in	ADP
ct-9450	89	24	handling	handling	NOUN
ct-9450	89	25	and	and	CCONJ
ct-9450	89	26	management	management	NOUN
ct-9450	89	27	of	of	ADP
ct-9450	89	28	mares	mare	NOUN
ct-9450	89	29	.	.	PUNCT
ct-9450	90	1	references	reference	NOUN
ct-9450	90	2	1	1	NUM
ct-9450	90	3	.	.	PUNCT
ct-9450	90	4	squires	squires	PROPN
ct-9450	90	5	el	el	PROPN
ct-9450	90	6	:	:	PUNCT
ct-9450	90	7	use	use	NOUN
ct-9450	90	8	of	of	ADP
ct-9450	90	9	progestins	progestin	NOUN
ct-9450	90	10	in	in	ADP
ct-9450	90	11	open	open	ADJ
ct-9450	90	12	and	and	CCONJ
ct-9450	90	13	pregnant	pregnant	ADJ
ct-9450	90	14	mares	mare	NOUN
ct-9450	90	15	.	.	PUNCT
ct-9450	91	1	anim	anim	NOUN
ct-9450	91	2	reprod	reprod	PROPN
ct-9450	91	3	sci	sci	PROPN
ct-9450	91	4	1993;33:183	1993;33:183	PROPN
ct-9450	91	5	-	-	PUNCT
ct-9450	91	6	193	193	NUM
ct-9450	91	7	.	.	PUNCT
ct-9450	92	1	2	2	X
ct-9450	92	2	.	.	X
ct-9450	92	3	daels	dael	NOUN
ct-9450	92	4	pf	pf	NOUN
ct-9450	92	5	:	:	PUNCT
ct-9450	92	6	induction	induction	NOUN
ct-9450	92	7	of	of	ADP
ct-9450	92	8	lactation	lactation	NOUN
ct-9450	92	9	and	and	CCONJ
ct-9450	92	10	adoption	adoption	NOUN
ct-9450	92	11	of	of	ADP
ct-9450	92	12	the	the	DET
ct-9450	92	13	orphan	orphan	NOUN
ct-9450	92	14	foal	foal	NOUN
ct-9450	92	15	.	.	PUNCT
ct-9450	93	1	proc	proc	PROPN
ct-9450	93	2	am	be	AUX
ct-9450	93	3	assoc	assoc	PROPN
ct-9450	93	4	equine	equine	PROPN
ct-9450	93	5	pract	pract	PROPN
ct-9450	93	6	2006	2006	NUM
ct-9450	93	7	.	.	PUNCT
ct-9450	94	1	3	3	X
ct-9450	94	2	.	.	X
ct-9450	94	3	hodgson	hodgson	PROPN
ct-9450	94	4	d	d	PROPN
ct-9450	94	5	,	,	PUNCT
ct-9450	94	6	howe	howe	NOUN
ct-9450	94	7	s	s	PROPN
ct-9450	94	8	,	,	PUNCT
ct-9450	94	9	jeffcott	jeffcott	PROPN
ct-9450	94	10	l	l	PROPN
ct-9450	94	11	,	,	PUNCT
ct-9450	94	12	et	et	PROPN
ct-9450	94	13	al	al	PROPN
ct-9450	94	14	:	:	PUNCT
ct-9450	94	15	effect	effect	NOUN
ct-9450	94	16	of	of	ADP
ct-9450	94	17	prolonged	prolonged	ADJ
ct-9450	94	18	use	use	NOUN
ct-9450	94	19	of	of	ADP
ct-9450	94	20	altrenogest	altrenogest	NOUN
ct-9450	94	21	on	on	ADP
ct-9450	94	22	behaviour	behaviour	NOUN
ct-9450	94	23	in	in	ADP
ct-9450	94	24	mares	mare	NOUN
ct-9450	94	25	.	.	PUNCT
ct-9450	95	1	vet	vet	NOUN
ct-9450	95	2	j	j	PROPN
ct-9450	95	3	2005;169:113	2005;169:113	NUM
ct-9450	95	4	-	-	SYM
ct-9450	95	5	115	115	NUM
ct-9450	95	6	.	.	PUNCT
ct-9450	96	1	clinical	clinical	ADJ
ct-9450	96	2	theriogenology	theriogenology	NOUN
ct-9450	96	3	•	•	NOUN
ct-9450	96	4	volume	volume	NOUN
ct-9450	96	5	12	12	NUM
ct-9450	96	6	number	number	NOUN
ct-9450	96	7	4	4	NUM
ct-9450	96	8	•	•	NOUN
ct-9450	96	9	december	december	PROPN
ct-9450	96	10	2020	2020	NUM
ct-9450	96	11	514	514	NUM
ct-9450	96	12	4	4	NUM
ct-9450	96	13	.	.	PUNCT
ct-9450	96	14	hinrichs	hinrichs	PROPN
ct-9450	96	15	k	k	PROPN
ct-9450	96	16	,	,	PUNCT
ct-9450	96	17	sertich	sertich	PROPN
ct-9450	96	18	pl	pl	PROPN
ct-9450	96	19	,	,	PUNCT
ct-9450	96	20	kenney	kenney	PROPN
ct-9450	96	21	rm	rm	PROPN
ct-9450	96	22	:	:	PUNCT
ct-9450	96	23	use	use	NOUN
ct-9450	96	24	of	of	ADP
ct-9450	96	25	altrenogest	altrenog	ADJ
ct-9450	96	26	to	to	PART
ct-9450	96	27	prepare	prepare	VERB
ct-9450	96	28	ovariectomized	ovariectomize	VERB
ct-9450	96	29	mares	mare	NOUN
ct-9450	96	30	as	as	ADP
ct-9450	96	31	embryo	embryo	NOUN
ct-9450	96	32	transfer	transfer	NOUN
ct-9450	96	33	recipients	recipient	NOUN
ct-9450	96	34	.	.	PUNCT
ct-9450	97	1	theriogenology	theriogenology	NOUN
ct-9450	97	2	1986;26:455	1986;26:455	NUM
ct-9450	97	3	-	-	SYM
ct-9450	97	4	460	460	NUM
ct-9450	97	5	.	.	NOUN
ct-9450	97	6	5	5	NUM
ct-9450	97	7	.	.	X
ct-9450	97	8	hornberger	hornberger	NOUN
ct-9450	98	1	k	k	PROPN
ct-9450	98	2	,	,	PUNCT
ct-9450	98	3	lyman	lyman	PROPN
ct-9450	98	4	cc	cc	PROPN
ct-9450	98	5	,	,	PUNCT
ct-9450	98	6	baldrighi	baldrighi	PROPN
ct-9450	98	7	jm	jm	PROPN
ct-9450	98	8	,	,	PUNCT
ct-9450	98	9	et	et	PROPN
ct-9450	98	10	al	al	PROPN
ct-9450	98	11	:	:	PUNCT
ct-9450	98	12	plasma	plasma	NOUN
ct-9450	98	13	altrenogest	altrenogest	NOUN
ct-9450	98	14	concentrations	concentration	NOUN
ct-9450	98	15	in	in	ADP
ct-9450	98	16	mares	mare	NOUN
ct-9450	98	17	after	after	ADP
ct-9450	98	18	intrarectal	intrarectal	ADJ
ct-9450	98	19	or	or	CCONJ
ct-9450	98	20	intravaginal	intravaginal	ADJ
ct-9450	98	21	administration	administration	NOUN
ct-9450	98	22	.	.	PUNCT
ct-9450	99	1	clinical	clinical	ADJ
ct-9450	99	2	theriogenology	theriogenology	NOUN
ct-9450	99	3	2019;11:59	2019;11:59	NUM
ct-9450	99	4	-	-	SYM
ct-9450	99	5	65	65	NUM
ct-9450	99	6	.	.	NOUN
ct-9450	100	1	6	6	NUM
ct-9450	100	2	.	.	X
ct-9450	100	3	fda	fda	PROPN
ct-9450	100	4	.	.	PUNCT
ct-9450	100	5	animal	animal	NOUN
ct-9450	100	6	drug	drug	NOUN
ct-9450	100	7	safety	safety	NOUN
ct-9450	100	8	communication	communication	NOUN
ct-9450	100	9	:	:	PUNCT
ct-9450	100	10	fda	fda	PROPN
ct-9450	100	11	highlights	highlight	VERB
ct-9450	100	12	potential	potential	ADJ
ct-9450	100	13	health	health	NOUN
ct-9450	100	14	risks	risk	NOUN
ct-9450	100	15	to	to	ADP
ct-9450	100	16	people	people	NOUN
ct-9450	100	17	exposed	expose	VERB
ct-9450	100	18	to	to	ADP
ct-9450	100	19	altrenogest	altrenogest	NOUN
ct-9450	100	20	products	product	NOUN
ct-9450	100	21	for	for	ADP
ct-9450	100	22	horses	horse	NOUN
ct-9450	100	23	or	or	CCONJ
ct-9450	100	24	pigs	pig	NOUN
ct-9450	100	25	.	.	PUNCT
ct-9450	101	1	2018	2018	NUM
ct-9450	102	1	[	[	X
ct-9450	102	2	cited	cite	VERB
ct-9450	102	3	2020	2020	NUM
ct-9450	102	4	january	january	PROPN
ct-9450	102	5	]	]	PUNCT
ct-9450	102	6	;	;	PUNCT
ct-9450	102	7	available	available	ADJ
ct-9450	102	8	from	from	ADP
ct-9450	102	9	:	:	PUNCT
ct-9450	102	10	https://www.fda.gov/animalveterinary/cvm-updates/fda-animal-drug-safety-communication-fda-highlights-potential-health-risks-peopleexposed	https://www.fda.gov/animalveterinary/cvm-updates/fda-animal-drug-safety-communication-fda-highlights-potential-health-risks-peopleexpose	VERB
ct-9450	102	11	.	.	PUNCT
ct-9450	103	1	7	7	X
ct-9450	103	2	.	.	X
ct-9450	103	3	shideler	shideler	PROPN
ct-9450	103	4	rk	rk	PROPN
ct-9450	103	5	,	,	PUNCT
ct-9450	103	6	squires	squires	PROPN
ct-9450	103	7	el	el	PROPN
ct-9450	103	8	,	,	PUNCT
ct-9450	103	9	voss	voss	PROPN
ct-9450	103	10	jl	jl	PROPN
ct-9450	103	11	,	,	PUNCT
ct-9450	103	12	et	et	PROPN
ct-9450	103	13	al	al	PROPN
ct-9450	103	14	:	:	PUNCT
ct-9450	103	15	progestagen	progestagen	NOUN
ct-9450	103	16	therapy	therapy	NOUN
ct-9450	103	17	of	of	ADP
ct-9450	103	18	ovariectomized	ovariectomize	VERB
ct-9450	103	19	pregnant	pregnant	ADJ
ct-9450	103	20	mares	mare	NOUN
ct-9450	103	21	.	.	PUNCT
ct-9450	104	1	j	j	PROPN
ct-9450	104	2	reprod	reprod	PROPN
ct-9450	104	3	fertil	fertil	VERB
ct-9450	104	4	suppl	suppl	ADJ
ct-9450	104	5	1982;32:459	1982;32:459	NUM
ct-9450	104	6	-	-	SYM
ct-9450	104	7	464	464	NUM
ct-9450	104	8	.	.	PUNCT
ct-9450	105	1	8	8	X
ct-9450	105	2	.	.	X
ct-9450	105	3	squires	squires	PROPN
ct-9450	105	4	el	el	PROPN
ct-9450	105	5	,	,	PUNCT
ct-9450	105	6	heesemann	heesemann	PROPN
ct-9450	105	7	cp	cp	PROPN
ct-9450	105	8	,	,	PUNCT
ct-9450	105	9	webel	webel	ADJ
ct-9450	105	10	sk	sk	PROPN
ct-9450	105	11	,	,	PUNCT
ct-9450	105	12	et	et	PROPN
ct-9450	105	13	al	al	PROPN
ct-9450	105	14	:	:	PUNCT
ct-9450	105	15	relationship	relationship	NOUN
ct-9450	105	16	of	of	ADP
ct-9450	105	17	altrenogest	altrenogest	NOUN
ct-9450	105	18	to	to	ADP
ct-9450	105	19	ovarian	ovarian	ADJ
ct-9450	105	20	activity	activity	NOUN
ct-9450	105	21	,	,	PUNCT
ct-9450	105	22	hormone	hormone	NOUN
ct-9450	105	23	concentrations	concentration	NOUN
ct-9450	105	24	and	and	CCONJ
ct-9450	105	25	fertility	fertility	NOUN
ct-9450	105	26	of	of	ADP
ct-9450	105	27	mares	mare	NOUN
ct-9450	105	28	.	.	PUNCT
ct-9450	106	1	j	j	PROPN
ct-9450	106	2	anim	anim	NOUN
ct-9450	106	3	sci	sci	PROPN
ct-9450	106	4	1983;56:901	1983;56:901	PROPN
ct-9450	106	5	-	-	SYM
ct-9450	106	6	910	910	NUM
ct-9450	106	7	.	.	PUNCT
ct-9450	106	8	9	9	NUM
ct-9450	106	9	.	.	X
ct-9450	106	10	ellis	ellis	PROPN
ct-9450	106	11	ke	ke	PROPN
ct-9450	106	12	,	,	PUNCT
ct-9450	106	13	council	council	PROPN
ct-9450	106	14	-	-	PUNCT
ct-9450	106	15	troche	troche	PROPN
ct-9450	106	16	rm	rm	PROPN
ct-9450	106	17	,	,	PUNCT
ct-9450	106	18	von	von	PROPN
ct-9450	106	19	dollen	dollen	PROPN
ct-9450	106	20	ka	ka	PROPN
ct-9450	106	21	,	,	PUNCT
ct-9450	106	22	et	et	PROPN
ct-9450	106	23	al	al	PROPN
ct-9450	106	24	:	:	PUNCT
ct-9450	106	25	pharmacokinetics	pharmacokinetic	NOUN
ct-9450	106	26	of	of	ADP
ct-9450	106	27	intrarectal	intrarectal	ADJ
ct-9450	106	28	altrenogest	altrenogest	NOUN
ct-9450	106	29	in	in	ADP
ct-9450	106	30	horses	horse	NOUN
ct-9450	106	31	.	.	PUNCT
ct-9450	107	1	j	j	PROPN
ct-9450	107	2	equine	equine	PROPN
ct-9450	107	3	vet	vet	NOUN
ct-9450	107	4	sci	sci	PROPN
ct-9450	107	5	2019;72:41	2019;72:41	NUM
ct-9450	107	6	-	-	SYM
ct-9450	107	7	46	46	NUM
ct-9450	107	8	.	.	PUNCT
ct-9450	107	9	10	10	NUM
ct-9450	107	10	.	.	PUNCT
ct-9450	108	1	storer	storer	PROPN
ct-9450	108	2	wa	wa	PROPN
ct-9450	108	3	,	,	PUNCT
ct-9450	108	4	thompson	thompson	PROPN
ct-9450	108	5	jr	jr	PROPN
ct-9450	108	6	dl	dl	PROPN
ct-9450	108	7	,	,	PUNCT
ct-9450	108	8	gilley	gilley	PROPN
ct-9450	108	9	rm	rm	PROPN
ct-9450	108	10	,	,	PUNCT
ct-9450	108	11	et	et	PROPN
ct-9450	108	12	al	al	PROPN
ct-9450	108	13	:	:	PUNCT
ct-9450	108	14	evaluation	evaluation	NOUN
ct-9450	108	15	of	of	ADP
ct-9450	108	16	injectable	injectable	ADJ
ct-9450	108	17	sustained	sustain	VERB
ct-9450	108	18	release	release	NOUN
ct-9450	108	19	progestin	progestin	NOUN
ct-9450	108	20	formulations	formulation	NOUN
ct-9450	108	21	for	for	ADP
ct-9450	108	22	suppression	suppression	NOUN
ct-9450	108	23	of	of	ADP
ct-9450	108	24	estrus	estrus	NOUN
ct-9450	108	25	and	and	CCONJ
ct-9450	108	26	ovulation	ovulation	NOUN
ct-9450	108	27	in	in	ADP
ct-9450	108	28	mares	mare	NOUN
ct-9450	108	29	.	.	PUNCT
ct-9450	109	1	j	j	PROPN
ct-9450	109	2	equine	equine	PROPN
ct-9450	109	3	vet	vet	NOUN
ct-9450	109	4	sci	sci	PROPN
ct-9450	109	5	2009;29:33	2009;29:33	NUM
ct-9450	109	6	-	-	SYM
ct-9450	109	7	36	36	NUM
ct-9450	109	8	.	.	PUNCT
ct-9450	109	9	11	11	NUM
ct-9450	109	10	.	.	PUNCT
ct-9450	110	1	machnik	machnik	PROPN
ct-9450	110	2	m	m	PROPN
ct-9450	110	3	,	,	PUNCT
ct-9450	110	4	hegger	hegger	PROPN
ct-9450	110	5	i	i	PROPN
ct-9450	110	6	,	,	PUNCT
ct-9450	110	7	kietzmann	kietzmann	PROPN
ct-9450	110	8	m	m	PROPN
ct-9450	110	9	,	,	PUNCT
ct-9450	110	10	et	et	PROPN
ct-9450	110	11	al	al	PROPN
ct-9450	110	12	:	:	PUNCT
ct-9450	110	13	pharmacokinetics	pharmacokinetic	NOUN
ct-9450	110	14	of	of	ADP
ct-9450	110	15	altrenogest	altrenogest	NOUN
ct-9450	110	16	in	in	ADP
ct-9450	110	17	horses	horse	NOUN
ct-9450	110	18	.	.	PUNCT
ct-9450	111	1	j	j	PROPN
ct-9450	111	2	vet	vet	NOUN
ct-9450	111	3	pharmacol	pharmacol	PROPN
ct-9450	111	4	ther	ther	ADV
ct-9450	111	5	2007;30:86	2007;30:86	PROPN
ct-9450	111	6	-	-	SYM
ct-9450	111	7	90	90	NUM
ct-9450	111	8	.	.	PUNCT
ct-9450	111	9	12	12	NUM
ct-9450	111	10	.	.	PUNCT
ct-9450	112	1	mcconaghy	mcconaghy	PROPN
ct-9450	112	2	ff	ff	NOUN
ct-9450	112	3	,	,	PUNCT
ct-9450	112	4	black	black	ADJ
ct-9450	112	5	l	l	NOUN
ct-9450	112	6	,	,	PUNCT
ct-9450	112	7	colgan	colgan	PROPN
ct-9450	112	8	s	s	PROPN
ct-9450	112	9	,	,	PUNCT
ct-9450	112	10	et	et	PROPN
ct-9450	112	11	al	al	PROPN
ct-9450	112	12	:	:	PUNCT
ct-9450	112	13	studies	study	NOUN
ct-9450	112	14	of	of	ADP
ct-9450	112	15	the	the	DET
ct-9450	112	16	pharmacokinetic	pharmacokinetic	ADJ
ct-9450	112	17	profile	profile	NOUN
ct-9450	112	18	,	,	PUNCT
ct-9450	112	19	in	in	ADP
ct-9450	112	20	vivo	vivo	ADJ
ct-9450	112	21	efficacy	efficacy	NOUN
ct-9450	112	22	and	and	CCONJ
ct-9450	112	23	safety	safety	NOUN
ct-9450	112	24	of	of	ADP
ct-9450	112	25	injectable	injectable	ADJ
ct-9450	112	26	altrenogest	altrenogest	NOUN
ct-9450	112	27	for	for	ADP
ct-9450	112	28	the	the	DET
ct-9450	112	29	suppression	suppression	NOUN
ct-9450	112	30	of	of	ADP
ct-9450	112	31	oestrus	oestrus	NOUN
ct-9450	112	32	in	in	ADP
ct-9450	112	33	mares	mare	NOUN
ct-9450	112	34	.	.	PUNCT
ct-9450	113	1	aust	aust	PROPN
ct-9450	113	2	vet	vet	PROPN
ct-9450	113	3	j	j	PROPN
ct-9450	113	4	2016;94:248	2016;94:248	PROPN
ct-9450	113	5	-	-	SYM
ct-9450	113	6	255	255	NUM
ct-9450	113	7	.	.	PUNCT
ct-9450	114	1	13	13	NUM
ct-9450	114	2	.	.	PUNCT
ct-9450	115	1	european	european	PROPN
ct-9450	115	2	medicines	medicine	NOUN
ct-9450	115	3	agency	agency	NOUN
ct-9450	115	4	.	.	PUNCT
ct-9450	116	1	committee	committee	NOUN
ct-9450	116	2	for	for	ADP
ct-9450	116	3	medicinal	medicinal	ADJ
ct-9450	116	4	products	product	NOUN
ct-9450	116	5	for	for	ADP
ct-9450	116	6	veterinary	veterinary	ADJ
ct-9450	116	7	use	use	NOUN
ct-9450	116	8	.	.	PUNCT
ct-9450	117	1	2004	2004	NUM
ct-9450	117	2	.	.	PUNCT
ct-9450	118	1	[	[	X
ct-9450	118	2	cited	cite	VERB
ct-9450	118	3	2019	2019	NUM
ct-9450	118	4	november	november	PROPN
ct-9450	118	5	]	]	PUNCT
ct-9450	118	6	;	;	PUNCT
ct-9450	118	7	available	available	ADJ
ct-9450	118	8	from	from	ADP
ct-9450	118	9	:	:	PUNCT
ct-9450	118	10	http://www.ema.europa.eu/docs/en_gb/document_library/maximum_residue_limits__report/2009/11/wc500009996.pdf	http://www.ema.europa.eu/docs/en_gb/document_library/maximum_residue_limits__report/2009/11/wc500009996.pdf	NOUN
ct-9450	118	11	.	.	PUNCT
ct-9450	119	1	14	14	NUM
ct-9450	119	2	.	.	PUNCT
ct-9450	120	1	norman	norman	PROPN
ct-9450	120	2	s	s	PART
ct-9450	120	3	:	:	PUNCT
ct-9450	120	4	factors	factor	NOUN
ct-9450	120	5	influencing	influence	VERB
ct-9450	120	6	the	the	DET
ct-9450	120	7	incidence	incidence	NOUN
ct-9450	120	8	of	of	ADP
ct-9450	120	9	dystocia	dystocia	NOUN
ct-9450	120	10	in	in	ADP
ct-9450	120	11	beef	beef	NOUN
ct-9450	120	12	heifers	heifer	NOUN
ct-9450	120	13	.	.	PUNCT
ct-9450	121	1	vet	vet	NOUN
ct-9450	121	2	sci;2002	sci;2002	ADP
ct-9450	121	3	,	,	PUNCT
ct-9450	121	4	university	university	NOUN
ct-9450	121	5	of	of	ADP
ct-9450	121	6	queensland	queensland	PROPN
ct-9450	121	7	.	.	PUNCT
ct-9450	122	1	https://espace.library.uq.edu.au/view/uq:157957	https://espace.library.uq.edu.au/view/uq:157957	VERB
ct-9450	122	2	15	15	NUM
ct-9450	122	3	.	.	PUNCT
ct-9450	123	1	stirrat	stirrat	PROPN
ct-9450	123	2	li	li	PROPN
ct-9450	123	3	,	,	PUNCT
ct-9450	123	4	o’reilly	o’reilly	ADV
ct-9450	123	5	jr	jr	PROPN
ct-9450	123	6	,	,	PUNCT
ct-9450	123	7	barr	barr	PROPN
ct-9450	123	8	sm	sm	PROPN
ct-9450	123	9	,	,	PUNCT
ct-9450	123	10	et	et	PROPN
ct-9450	123	11	al	al	PROPN
ct-9450	123	12	:	:	PUNCT
ct-9450	123	13	decreased	decrease	VERB
ct-9450	123	14	maternal	maternal	ADJ
ct-9450	123	15	hypothalamic	hypothalamic	ADJ
ct-9450	123	16	-	-	PUNCT
ct-9450	123	17	pituitary	pituitary	ADJ
ct-9450	123	18	-	-	PUNCT
ct-9450	123	19	adrenal	adrenal	ADJ
ct-9450	123	20	axis	axis	NOUN
ct-9450	123	21	activity	activity	NOUN
ct-9450	123	22	in	in	ADP
ct-9450	123	23	very	very	ADV
ct-9450	123	24	severely	severely	ADV
ct-9450	123	25	obese	obese	ADJ
ct-9450	123	26	pregnancy	pregnancy	NOUN
ct-9450	123	27	:	:	PUNCT
ct-9450	123	28	associations	association	NOUN
ct-9450	123	29	with	with	ADP
ct-9450	123	30	birthweight	birthweight	NOUN
ct-9450	123	31	and	and	CCONJ
ct-9450	123	32	gestation	gestation	NOUN
ct-9450	123	33	at	at	ADP
ct-9450	123	34	delivery	delivery	NOUN
ct-9450	123	35	.	.	PUNCT
ct-9450	124	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
ct-9450	124	2	2016;63:135	2016;63:135	PROPN
ct-9450	124	3	-	-	SYM
ct-9450	124	4	143	143	NUM
ct-9450	124	5	.	.	PUNCT
ct-9450	124	6	16	16	NUM
ct-9450	124	7	.	.	PUNCT
ct-9450	124	8	crew	crew	PROPN
ct-9450	124	9	rc	rc	PROPN
ct-9450	124	10	,	,	PUNCT
ct-9450	124	11	mark	mark	PROPN
ct-9450	124	12	pj	pj	PROPN
ct-9450	124	13	,	,	PUNCT
ct-9450	124	14	clarke	clarke	PROPN
ct-9450	124	15	mw	mw	PROPN
ct-9450	124	16	,	,	PUNCT
ct-9450	124	17	et	et	PROPN
ct-9450	124	18	al	al	PROPN
ct-9450	124	19	:	:	PUNCT
ct-9450	124	20	obesity	obesity	NOUN
ct-9450	124	21	disrupts	disrupt	VERB
ct-9450	124	22	the	the	DET
ct-9450	124	23	rhythmic	rhythmic	ADJ
ct-9450	124	24	profiles	profile	NOUN
ct-9450	124	25	of	of	ADP
ct-9450	124	26	maternal	maternal	ADJ
ct-9450	124	27	and	and	CCONJ
ct-9450	124	28	fetal	fetal	ADJ
ct-9450	124	29	progesterone	progesterone	NOUN
ct-9450	124	30	in	in	ADP
ct-9450	124	31	rat	rat	NOUN
ct-9450	124	32	pregnancy	pregnancy	NOUN
ct-9450	124	33	.	.	PUNCT
ct-9450	125	1	biol	biol	PROPN
ct-9450	125	2	reprod	reprod	PROPN
ct-9450	125	3	2016;95:55	2016;95:55	NUM
ct-9450	125	4	.	.	PUNCT
ct-9450	126	1	clinical	clinical	ADJ
ct-9450	126	2	theriogenology	theriogenology	NOUN
ct-9450	126	3	•	•	NOUN
ct-9450	126	4	volume	volume	NOUN
ct-9450	126	5	12	12	NUM
ct-9450	126	6	number	number	NOUN
ct-9450	126	7	4	4	NUM
ct-9450	126	8	•	•	NOUN
ct-9450	126	9	december	december	PROPN
ct-9450	126	10	2020515	2020515	NUM